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Summary 
Within the regulation of blood pressure, the renin-angiotensin system (RAS) plays an 
essential role with AngII causing vasoconstriction, which increases the blood 
pressure. AngII is formed after ACE ar cleaved by AngI. We hypothesize that the 
blunting of AngII production with concomitant exercise reduces improvements in 
metabolic fitness by removing an important stimulus for capillary growth in exercised 
muscles. The aim of this research was to expose the pathway by which AngII and 
ACE are implicated in exercise-induced capillary growth of human muscle. We show 
that highest increases in indices of metabolic strain are observed after high intense 
exercise bouts and that the increase in AngII is ACE genotype dependent. 
Furthermore, subjects with the ACE-II genotype had a significant higher capillary 
perfusion in the finger after exercise. Our findings of our ACE inhibition study 
support the view that an angiotensin-regulated mechanism affects the hypoxia-
specific gene response in peripheral muscle to endurance exercise and support the 
notion that the muscle’s transcript regulation by ACE inhibition is related to muscle 
oxygenation during exercise.  This indicates that there is a shift in the activation of 
the gene program from muscle fibres to the surrounding interstitium after ACE 
inhibition. In a training study we identified a correlation between increases in 
VO2max and the changes in capillary-to-fibre-ratio. We further observed that 
variability in the cardiovascular response, based on VO2max and heart rate at rest, 
was related to the ACE I/D genotype. Our findings that physiological improvements 
after exercise are dependent on ACE levels, both due to different ACE genotypes and 
to taking ACE inhibitors could have clinical repercussions. It may explain the 
individual variation in the response to exercise rehabilitation in aerobic power and 
oxygen uptake. These differences in exercise-induced improvements have rarely 
been valued in pharmacological studies of hypertension and exercise rehabilitation. 
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Chapter 1: Introduction 
 
High blood pressure (hypertension) indicates the deterioration of metabolic fitness 
and is one of the most frequent metabolic risk factors for disease in Western 
countries (North of England Hypertension Guideline Development Group, 2004). The 
risk to develop hypertension and associated metabolic syndromes increases with age 
(Burt et al. 1995). Consequently, hypertension is a major target of the current 
pharmacological treatments producing yearly expenses in the order of 100s of 
million Euros in middle-sized European countries alone (North of England 
Hypertension Guideline Development Group, 2004) 
 
Amongst the factors that regulate  blood pressure, the renin-angiotensin system 
(RAS) plays an essential role. Renin is produced in the kidneys when the blood 
pressure at the juxtaglomerular apparatus decreases (< 90 mmHg systolic blood 
pressure) or when there is a decreased sodium chloride delivery to the macula densa 
(Silbernagl et al. 2001). Angiotensinogen, a plasma protein synthesized in the liver, 
is cleaved by renin and forms angiotensin I (AngI). AngI appears to have no 
biological activity but circulating AngI is cleaved by the angiotensin-converting 
enzyme (ACE) to form angiotensin II (AngII).  AngII causes vasoconstriction; water 
and salt retention, stimulates releases of aldosterone from the adrenal cortex and 
stimulates capillary growth in blood flow-induced angiogenesis in skeletal muscle 
(Petersen and Greene, 2007). 
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Angiotensin-converting enzyme (ACE) 
ACE is a dipeptidipeptidyl-carbo-peptidase which is located in plasma, pulmonary 
and vascular endothelial cells and the heart (Brewster and Perazella 2004) and 
has the highest density in the lungs. ACE is secreted by pulmonary and renal 
endothelial cells and mediates extracellular volume and arterial vasoconstriction. 
Besides of converting AngI to AngII, ACE inhibits bradykinin, a potent vasodilator 
which can stimulate the release of vasodilating prostaglandins and nitric oxide. 
Within an individual the plasma ACE levels are very stable (Alhenc-Gelas et al. 
1991), however there are remarkable interindividual variations (Cambien et al. 
1988, Tiret et al. 1992). These variations are due to the existence of 
polymorphism in the ACE gene and environmental factors such as physical activity 
and thermal stress (Staessen et al. 1987); Kosunen J Appl Physiol 41(3), 1976; 
Danser et al. 2007). Besides ACE there also exists ACE2 which is mainly expressed 
in vascular endothelial cells of the heart and kidney. The general catalytic function 
of ACE2 is equivalent as that of ACE and about 40% of the catalytic site of ACE2 
correspondents to ACE.  However ACE2 catalyses the specific petidyl cleavages 
including cleavages of the carbosyl terminal phenylalanine residue of AngII into 
the vasodilator angiotensin-(1-9). So ACE2 can function antagonistically to ACE by 
destroying AngII and creating angiotensin-(1-9) (Vickers et al. 2002; Donoghe et 
al. 2000). 
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A major strategy of the current pharmacological treatments against hypertension 
consists in the lowering of serum AngII levels by pharmacological inhibition of ACE. 
This medication develops a generally positive effect on mortality and ACE inhibitors 
are among the most prescribed medication worldwide (Danser et al. 2007).  
Within intron 16 on the ACE gene people have an insertion (I) or deletion (D) of the 
287-base pair which results in three different genotypes: ACE-II, ACE-DD and ACE-
ID.  Subjects with the presence of I allele in the ACE-ID and ACE-II  genotypes have 
respectively approximately 30% and 60% lower plasma ACE activity (Rigat et al. 
1990) and also higher tissue activity levels than ACE-DD subjects (Costerousse et al. 
1993; Danser et al. 1995). It is known that people with the D-allele have a higher 
chance of getting hypertension (Chiang et al. 1996).  Insertion of the I allele seems 
to be related to enhanced endurance performance, while deletion of the I allele 
seems to be associated with power- and strength performance (Nazarov et al. 2001; 
Qi et al. 2008). 
The ACE I/D polymorphism is one of the over 160 polymorphisms at the ACE Locus . 
The physiological importance of the I/D polymorphism was discovered by its 
association with plasma ACE levels.  There is a possibility for more functional 
polymorphisms.  (Villard et al. 1996) Several investigators started studying the 
association between other variants in the gene and plasma levels, to find functional 
polymorphisms. Many of them are not in linkage disequilibrium with the ACE I/D 
polymorphism. (Sayed-Tabatabaei et al. 2006) 2 quantitative trait loci (QTLs), 
located on chromosome 4, are suggested to be functional polymorphissms. 
(Kammerer et al. 2004)  
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ACE inhibition can reduce the cross section of muscle fibers. (Morley, 2009, 
Sumukadas et al. 2006, Zoll et al. 2006) .  Genetic inhibition of ACE can manifest in 
increased trainability of aerobic fitness while activities demanding a high power is 
negatively affected (Jones et al. 2002). It has been found in a large cohort study 
that genetic inhibition of ACE via the I allele in the ACE genotype  can manifest in 
reduced trainability of aerobic fitness (Defoor et al. 2006) and that subjects with the 
ACE I show improved gains in maximal oxygen uptake with exercise rehabilitation 
(Danser et al. 2007; Defoor et al. 2006). Similarly and ACE inhibition blunts load-
induced muscle growth in rats (Gordon et al. 2001).   
This difference in increased trainability is possibly explained by modified transcript 
expression of pro-angiogenic factors, which reflects the mechanism that instructs the 
elevation in muscle capillarity post exercise (Schmutz et al. 2010).  This transcript 
expression is lower in genotypes being homozygous (ACE-II) or heterozygous (ACE-
ID) for the ‘I-allele’ (Vaughan et al. 2013).   Capillary growth after exercise is 
reflected by elevated expression of a number of factors involved in the activation 
and stabilization of endothelial cells. In particular it is suggested that Tenascin-C 
mediates the effect of the vasoconstrictor AngII on growth of blood vessels because 
it is induced by AngII and is expressed at high levels in vascular structures in 
hypertension. Pharmacological inhibition of ACE blunts the muscle response of the 
pro-angiogenic factor Tenascin-C to endurance training in coronary artery disease 
patients (Zoll et al. 2006)   Besides of Tenascin-C, hypoxia sensor HIF-1α is known 
to provokes in the muscle under hypoxia a specific gene expression response 
causing remodelling of existing blood vessels, a shift towards glycolytic metabolism 
and altered myogenic regulation in muscle as modified by the level of muscle 
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activation. The negative impact of ACE inhibition on endurance performance in man 
may be explained by the ‘double’ role of AngII, in vasoconstriction and capillary 
growth (angiogenesis). In resting muscle, the role of AngII is to restrict blood from 
entering non-active muscles in order to direct metabolic substrates to active tissues 
with enhanced energy turnover (Andersen and Saltin 1985). The AngII-mediated 
vasoconstriction is overridden with the onset of contraction through flow-induced 
dilatation of conduit arteries and arterioles and is expected to promote angiogenesis 
by activating the endothelial cell population that constitutes the capillary wall 
(Brothers  et al. 2006; Hahn et al. 1995). Different studies support the notion that a 
switch in AngII action from arterioles to the endothelium of the perfused vessel 
lumen facilitates exercise-induced capillary growth in human skeletal muscle 
(Petersen et al. 2007; Staessen et al. 1987). Awareness of the existence of such a 
mechanism could develop major economic and clinical repercussions on current 
Health Care practice. Pharmacological inhibition of AngII action may have 
undesirable side effects, particularly, in the situation when one wants to exploit the 
sympatholytic and angiogenic benefits of physical therapy. This activity-dependent 
mechanism has rarely been valued in pharmacological studies of hypertension. An 
interaction between physical activity and angiotensin 2-mediated angiogenesis may 
also explain the large differences in therapeutic efficiency of current anti-
hypertensive treatment.  
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Figure 1: The renin angiotensin system 
After angiotensinogen is produced by the liver it can via renin be converted into 
AngI. AngI is converted into AngII via ACE. Angiotensin II mainly works via AT1 
recepter and has the opposite function via the AT2 receptor, but the AT2 receptor is 
not so much present in the adult human body. AngII can be converted into AngIII 
via angiotensinase which has no primary function in the body. AngII signalling can 
be modulated by ACE inhibitors, and AT1 receptor blockers. 
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Angiotensin II 
AngII elevates arterial pressure as a result of its vasoconstrictor action and indirect 
by increasing the extracellular fluid volume by decreasing the excretion of salt and 
water of the kidney. AngII mediates its functions through two receptors: AngII type 
1 receptor (AT1) and AngII type 2 receptor (AT2). Most of the recognized actions of 
AngII are mediated by AT1 receptors (Allen et al. 2000). In addition to the renal 
effects of increasing water and sodium retention, AT1 receptor activation evokes G-
protein-dependent and –independent responses in the arterial vascular smooth 
muscle (Kimura et al. 2004). This includes vasoconstriction, activation of the pro-
oxidant enzyme NAD(P)H oxidase (Lopez et al. 2003) and stimulation of vascular 
cell growth and proliferation (Wolf and Wenzell, 2004) and extracellular matrix 
formation (Otsuka et al. 1998). AT2 receptors are prevalent in fetal tissue, 
implicating a role in growth and development, and are expressed at much lower 
levels in adults. (Allen at al. 2000). Less is known about the regulation and action of 
the AT2 receptors. This could be the result of the limited distribution and density of 
AT2 in relation to AT1 and the antagonistic interaction those receptors could have. 
For instance, a few studies suggest that the effects of AT2 receptor activation 
promote vasodilatation and anti-proliferation (Siragy et al. 1999a; Siragy et al. 
1999b). 
AngII is degraded to angiotensin III by angiotensinase. 
 
 
  
13 
 
Angiotensin II and exercise 
 
During exercise the renin-agiotensin system is stimulated and there is an increase in 
renin activity (Fasola et al. 1966; Kotchen et al. 1971, Fagard et al. 1985). Various 
studies show increases in AngII after a maximal incremental exercise test (Aldigier et 
al. 1993, Miura et al. 1994, Staessen et al. 1987, Braith et al. 1992, Kato et al. 1996, 
Danielsen et al. 1988, Fagard et al. 1985) but not all studies (Shim et al. 2008, 
Blanchet et al. 2005). AngII concentrations are also elevated after non maximal 
incremental or submaximal exercise test (Warren et al. 2001, Pedersen et al. 1986, 
Kinugawa et al. 1992; 1996 & 1997, Maher et al. 1975, Katzman et al. 1987) but not 
in the study of Braith et al. 2003. A critical note by these studies is that they show 
very high AngII values in serum. As example Staessen has 20 pg/ml at rest while 
natural values of the ‘real’ serum AngII levels are near 10pg/ml (Nussberger et al. 
1986). 
It should be noted that the majority of studies on ACE had a clinical focus and that 
AngII measurements were carried out only in a few situations. The main studies 
about AngII related to exercise are described in more detail below. 
In the study of Staessen et al. (1987) subjects performed an incremental exercise 
test with 6 minutes of maintained external work load at 30% and 60% of their 
predetermined maximal exercise capacity. They found a positive correlation between 
plasma renin activity and AngII. Indicating that with increasing activity of plasma 
renin the plasma concentration of AngII augmented also. At 60% of the calculated 
maximal exercise capacity the slope of the regression line was steeper than at rest 
and at 30% of the calculated exercise capacity. This indicates that as the intensity of 
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exercise rise, the slope of the regression of plasma angtiotenisn II on renin activity 
become progressively steeper. 
The study of Aldigier et al. (1993) also shows an increase in AngII with increasing 
intensity. In the study performed eight normative male subjects consecutive exercise 
bouts at 20%, 40%, 60% and 80% of their peak power output (PPO) on a cycle 
ergometer. Compared to the resting levels there was an increase in Angiotensin II of 
1.50 (20% PPO), 1.48 (40% PPO), 3.18 (60% PPO) and 7.93 (80% PPO) times. Due 
to the relative long exercise steps, it should be noted that the increase in AngII is 
not likely to be related to the exercise duration but to the exercise intensity. What 
corresponds with the study of Staessen et al. (1987) is that there seems to be an 
exponential relationship between exercise intensity and AngII serum levels. 
As seen above, exercise increases the AngII levels with the highest increases seen 
after high intensity exercise. It is not clear how elevations in AngII are related to the 
exercise intensity and exercise duration but it seems to be exponential related to 
external power (Aldiger et al. 1993, Staessen et al. 1987). These studies had been 
done with different exercise protocols. It is therefore unclear how serum angiotensin 
II levels depend on the intensity and time of the exercise. 
We plotted data from different studies with submaximal exercise protocols into one 
figure (see figure 2). The studies had large differences in absolute angiotensin II 
values, so we normalized the values by rescaling the resting values to 1 and 
recalculated the other AngII levels. In the majority of studies the intensity level of 
the submaximal exercise was based on the persons VO2-max and in other studies on 
the subjects maximal workload or heart rate reserves.   
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Figure 2 shows that there seems to be a threshold at an intensity around 60% 
VO2max/ 70% of the workload which evokes a sudden increase in AngII levels. This 
steep increase in AngII occurred during exercise above the anaerobic threshold. 
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2a)  
 
Figure 2a-c: Increase in AngII levels as seen from the resting levels in 
different studies. Studies with submaximal exercise protocols depending on 
%workload (a, above),  %VO2-max (b, page 17) and heart rate reserve (c, page 
18).Values are normalized values by rescaling the resting values to 1 by dividing the 
mean values of the pre levels by itself and dividing the other post AngII levels by the 
same number. 
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2b) 
 
Figure 2b: description of figure 2 see page 16 
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2c) 
Figure 2c: description of figure 2 see page 16 
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An enhanced generation of angiotensin I might be considered to explain the 
steep increase in the plasma concentration of AngII during severe exercise. But 
according to Steasen et al. (1987), the capacity of the pulmonary vascular bed to 
convert AngI is very high comparing to the amount of the circulating decapeptide 
and is therefore not rate determining. 
Another reason could be a decreased breakdown of AngII. In vivo, AngII is 
very rapidly removed from the bloodstream and degraded by most tissues including 
the vascular endothelium. In contrast, the study of Kosunen et al. (1976) shows that 
the AngII concentration could remain enhanced for hours after exercise. It has been 
demonstrated in the dog that up to 75% of AngII is removed in one circulation by 
the liver, head, kidneys, and hindquarters when singly perfused, whereas no AngII 
disappears across the pulmonary circulation. Four male athletes were investigated 
before and after running three times a 100m sprint with 5 minutes of rest in 
between. Direct after the last sprint there was a 4.2 fold increase in AngII levels 
compared to the resting levels and a 6.6 fold increase after 30 minutes of exercise 
and after  1 hour, 3 hours, and 6 hours of exercise there was respectively still a 3.7, 
3.0, 1.7 times higher level of AngII. 
An example for a potential mechanism of modulated AngII breakdown  above the 
anaerobic threshold could be the induced acidosis evoked by exercise. With exercise 
at low intensity levels the pH hardly changes. However, at higher intensity exercise 
when the aerobic capacity is no longer sufficient, the anaerobic mechanisms are 
invoked and the pH can decline below 7.2 (Staessen et al. 1987). The 
angiotensinase activity, which breaks down AngII into angiotensin III, is pH 
20 
 
dependent. Within the pH range of 7.0 to 7.4 the activity can be reduced by 50% 
and can so inhibit the degradation of AngII thereby leading to an increase in AngII 
levels (Khairallah, 1967). 
 
ACE genotype and exercise 
 
Verry little is known what the effect is of the ACE genotype during and after exercise 
upon the AngII levels. In the study of Woods et al. (2003) they stated that there 
was no influence of genotype upon the exercise-related rise in ACE activity. Ang II 
levels were unrelated to ACE genotype and ACE activity. An important note is that 
the study only included six participants and the protocol of the cycling test was 
submaximal at 70% VO2-max.   
 
ACE inhibition and exercise 
 
Two studies investigated the effect of ACE inhibition in AngII levels during exercise. 
The studies of Aldigier et al. (1993) and Miura et al. (1994), as described above, had 
a cross-over design with a group of respectively 8 and 3 normotensive Caucasian 
male participants, receiving 50 mg of the ACE inhibitor captopril for three days. The 
subjects also received a dose in the morning of the exercise test. In both studies 
lower AngII levels were observed in the group who took the ACE inhibitor. Miura et 
al. (1994) found a treatment effect (p=0.044), but Aldigier et al. (1987) did not 
identify a treatment effect (p=0.37). In the study of Gavin et al. (1985) the effect of 
lowering ACE levels by captopril was investigated on angiogenic growth factor 
responses in the muscle to exercise in rats. Vascular endothelial growth factor 
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(VEGF) functions via binding to the VEGF receptors Flk-1 and Flt-1.  They found that 
captopril did reduce Flk-1 mRNA 30–40%, independently of exercise but did not 
affect the rest or exercise levels of VEGF and Flt-1 mRNA. (Gavin et al. 1985) 
 
Angiotensin II and Circadian rhythm 
 
AngII shows a circadian rhythm in normal subjects whose acrophase is detectable in 
most studies early in the morning (Fersini et al. 1975, Cugini et al. 2004 Rittig et al. 
2006). Only the study of Veglio et al. (1987) reports a low-amplitude circadian 
rhythm of which its acrophase is in the late afternoon. The angiotensin converting 
enzyme (ACE) shows a circadian rhythm as well with its circadian acrophase in the 
afternoon, suggesting a negative feed-back (Cugini et al. 2004). The daily variation 
of the renin-angiotensin-aldosterone systes is influenced by many factors. Physical 
activity and rest affect both the mesor amplitude and acrophase (Cugini et al. 1978). 
Moreover, circadian rhythm seems to be influenced by the race. The circadian 
rhythm is absent in people with hypertension (Fersini et al. 1975, Cugini et al. 2004) 
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Aims and thesis outline 
 
The aim of this research was to expose the pathway by which AngII is implicated in 
exercise-induced capillary growth of human muscle. We hypothesize that the 
blunting of AngII production with concomitant exercise reduces improvements in 
metabolic fitness by removing an important stimulus for capillary growth in exercised 
muscle.  
In Chapter 2 it is described how serum AngII levels are increased after exercise 
and depend on exercise time and exercise intensity, and ACE I/D gene 
polymorphism related capillary perfusion.  Chapter 3 presents a study that exposes 
the role of AngII in angiogenic gene expression in exercised muscle by assessing the 
effect of ACE inhibition by medication with in chapter 4 from the same study the 
association of Tenascin-C with ACE-modulated muscle angiogenesis after endurance 
training. As adjustments to endurance exercise and elevated altitude have been 
shown to be affected by the ACE I/D gene polymorphism we assessed in a training 
study in Chapter 5 whether the response of the pathway that sets aerobic capacity 
would be modified by the ACE I/D gene polymorphism. The thesis is concluded with 
a general discussion in Chapter 6 of the implications of the results for our 
understanding of the relevance of AngII and ACE I/D gene polymorphism in the 
human body and the implication of inhibited AngII production during exercise. 
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Abstract 
 
During exercise the renin-angiotensin system is stimulated. We hypothesized that 
the increase in serum angiotensin II (AngII) levels after exercise is dependent on 
exercise intensity and duration and secondly that people with the ACE-II genotype 
will show a higher increase in AngII serum levels. We also assumed that perfusion of 
upper limbs is transiently reduced with maximal cycling exercise and that subjects 
with the ACE-II compared to the ACE-ID/DD genotype will have a higher capillary 
perfusion due to lower AngII levels. Ten healthy subjects completed a maximal 
exercise test, a 12-minutes exercise test at ventilatory threshold and a 3-minutes 
test at the respiratory compensation point. AngII serum levels and capillary 
recruitment of the skin in the third finger was measured before and after exercise 
and breath-by-breath gas exchange during exercise was assessed. Baseline levels of 
AngII levels were lower prior to the 3-minutes test which took place on average 5 
days after the last exercise. A two-fold increase compared to baseline levels was 
found for AngII only immediately after the 3-minutes test and not after the maximal 
exercise test and 12-minutes of exercise. Subjects without the I allele showed a 
decrease in AngII values after the maximal test in contrast to subjects with the ACE-
II/ID genotype. Subjects with the ACE-II genotype had a 1.8 times significant higher 
capillary perfusion in the finger after exercise. A trend was observed for a 34.3% 
decreased capillary recruitment in the ACE-ID/DD genotype after exercise. We 
conclude that the rise in AngII after exercise is intensity dependent and that 
variability in serum AngII and capillary perfusion is related to the ACE I/D 
polymorphism. 
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Introduction 
 
Angiotensin II (AngII) elevates arterial pressure because of its vasoconstrictor action 
and restricts blood from entering non-active muscles thereby directing metabolic 
substrates to active tissues with enhanced energy turnover (Andersen and Saltin 
1985). This mechanism helps to redirect blood to active muscles which work 
depends on the substrate supply (Secher et al. 1977). The AngII-mediated 
vasoconstriction is overridden with the onset of muscle contraction through flow-
induced dilatation of conduit arteries and arterioles and promotes angiogenesis by 
activating the endothelial cell population that constitutes the capillary wall (Brothers 
et al. 2006; Hahn et al. 1995). Different studies support the notion that a switch in 
AngII action from arterioles to the endothelium of the perfused vessel lumen 
facilitates exercise-induced capillary growth in human skeletal muscle (Petersen and 
Greene 2007; Staessen et al. 1987). There is evidence that the role of AngII in 
stimulating angiogenesis relies on capillary perfusion (Petersen and Greene 2009).  
During cycling exercise, the renin-angiotensin system is stimulated (Staessen et al. 
1987). Different studies show an increase in AngII after high intensity exercise, 
indicating that organs which cannot overcome AngII mediated vasoconstriction are 
decreasingly perfused (Fagard et al. 1985; Kosunen and Pakarinen 1976; Staessen  
et al. 1987; Aldigier et al. 1993). Limited studies investigated AngII levels related to 
exercise intensity and duration, but it seems that there is an increase in AngII at an 
intensity above the anaerobic threshold (Maher et al. 1975, Staessen et al. 1987, 
Miura et al. 1994). 
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Human subjects carrying the D-allele of the ACE I/D gene polymorphisms (i.e. ACE-
ID and ACE-DD genotypes) have respectively approximately 30% and 60% higher 
serum and tissue ACE activity and more serum AngI is converted via ACE to AngII 
than in subjects with the ACE-II genotype. However, only less than 20% of the 
variability in circulating ACE activity can be explained by the ACE I/D polymorphism 
(Danser et al. 2007). Subjects with  homozygous (ACE-II) or heterozygous (ACE-ID) 
for the ‘I-allele’ show reduced capillarity at rest but amplified mitochondrial 
biogenesis after bicycle-type endurance exercise and training, suggesting a critical 
role of ACE-modulated vascular tone in the regulation of the response to exercise 
(Defoor et al. 2006; Vaughan et al. 2013).  
We aimed to detect changes in human AngII levels after exercises at different 
intensities. We hypothesized that the increase in serum AngII after exercise is 
dependent on the exercise intensity and the exercise duration. We also hypothesized 
that people with the ACE-II genotype will show a higher increase in AngII serum 
levels after cycling exercise due to their lower AngII resting values (Vaughan et al. 
2013). In order to establish the suggested association between serum AngII and 
capillary perfusion with exercise (Petersen and Greene 2007), we tested whether 
serum AngII levels relate to exercise intensity and capillary perfusion in skin, in a 
body compartment being accessible during exercise, and whether this depends on 
the ACE I/D genotype. We assumed that perfusion of the finger is reduced with 
maximal cycling exercise and that subjects with the ACE-II genotype will have a 
higher capillary perfusion as they have less increased capillary density and a 
genetically-reduced potential for vasoconstriction (Vaughan et al. 2013; Brothers et 
al. 2006). Consequently, the relative change in perfusion and exercise-induced Ang-
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II levels in serum will be less pronounced than in D-genotypes for which 
vasoconstriction is overridden to a larger extent. 
 
Methods 
 
On three separate occasions, ten healthy young subjects performed three exercise 
tests on three separate occasions at the same time of the day on an electronically 
braked cycle ergometer (Excalibur Sport, Corval Lode B.V., Lode Medical 
Technology, Groningen, The Netherlands) in an air-conditioned room, where the 
temperature was kept between 15 and 20 degrees. All subjects gave written 
informed consent before participating in the study and participation was accepted 
according to the anamnesis forms. Before the first exercise test the subjects height 
and weight were measured. Mucosal cells were removed from inside of the cheeks 
by simply twirling/rubbing an ear bud against the inner cheek wall. During all tests 
the same personalized bicycle settings were used and the subjects were instructed 
to keep their pedal frequency constant at 80 rotations per minute (rpm), which was 
displayed on an analog display on the handlebar. Subjects were asked to rate their 
perceived exertion (RPE) on a 20 points Borg RPE scale every minute. 2ml of blood 
was collected from the upper arm via the median cubital vein before cycling and 3, 
6, 9 and 12 minutes after the cycling tests. Blood collection was done by a 
professional person via an intravenous cannula from the upper arm, while the 
subjects were in a sitting position. During the cycling exercise the subjects’ VO2
 
(oxygen uptake) and VCO2 (CO2 production) were measured breath by breath via 
expired air using a gas analyzing system (Cosmed Quark, Cosmed S. R. L., Rome, 
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Italy) and the subjects’ heart rate was measured with a Polar heart rate belt. From 
these data the maximal oxygen uptake (VO2peak) and the respiratory exchange ratio 
(RER) was established.  
At the first occasion the subjects performed a maximal incremental exercise test 
(maximal test). Subjects started cycling for three minutes at 50 Watt and the 
resistance was increased every minute by 25 watt until exhaustion. The test ended 
when the pedal frequency dropped below 65 rpm. After the first test the ventilatory 
threshold (VT) and respiratory compensation point were identified using the V-slope 
and ventilatory equivalent methods (Sue et al. 1988). To investigate the effect of 
exercise duration and intensity on AngII levels at and above the AT, subjects 
performed two other exercise tests at different occasions on the same time of the 
day with at least one day of rest in between. At the second occasion subjects cycled 
after a 3 minutes warm up of 50 Watt for 3 minutes at the intensity where they 
reached their RCP during the maximal test. At the third occasion subjects cycled for 
12 minutes at an intensity at which they reached their VT the maximal test. When 
the RPE of the subject during the tests dropped below 11 or was above 13, the 
external power was adjusted with 25 Watt. 
Capillary recruitment  
To assess perfusion in a non-active body compartment we used the capillary 
microscope which can non-invasively and directly visualize the perfusion of the skin 
in the finger. Absolute and relative capillary recruitment was measured before and 
directly after the maximal test as described previously (Serne et al. 1999). Briefly, 
two separate visual fields of 1 mm2 were recorded 1.5 mm proximal to the terminal 
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row of capillaries in the middle of the nail fold of the third finger. A characteristic 
capillary (i.e., a capillary that was constantly perfused and had an eye-catching 
morphological feature) was kept on the same spot exactly in the center of the visual 
field (marked by a dot on the monitor) to ensure that capillary density was 
measured in the exact same visual field during the entire experiment. Capillary 
density was counted as the number of continuously erythrocyte-perfused capillaries 
per square millimeter (n/mm²) during 15 seconds and after 4 minutes of arterial 
occlusion. Capillary recruitment was calculated as the relative increase in capillary 
density from baseline to capillary density after the 4 minutes of arterial occlusion. 
The procedure was repeated using a visual field adjacent to the first visual field and 
data concerning capillary densities are the mean of two measurements. The number 
of capillaries was counted off-line by a single experienced study physician (Jorn 
Woerdeman). 
Assessment of angiotensin II levels 
Blood (2 ml) was withdrawn from the venous cannula and put into vacutainers 
containing 60 l AngII inhibitor cocktail, comprising 13.35 l of O-Phenanthroline 
and Pepstatine A in DMSO mixed with 46.65 l of EDTA and PHMB in aqueous 
solution (SPI bio, Bertin pharma, Versailles, France). The samples were immediately 
centrifuged at 10,000 rpm (3,000 g), at 4oC for 12 min. The supernatants were 
separated, snap frozen in liquid nitrogen and stored at -80oC, transferred with dry 
ice to MMU Manchester and stored at -80oC until analysed. Plasma was eluted with 
C18 phenyl cartridge which were conditioned with 2 ml of methanol and then rinsed 
with 2 ml of water. 0.9 ml of cold plasma was rapidly passed through the cartridge 
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and subsequently washed with 1 ml of water. Absorbed angiotensins were eluted 
with 1 ml of methanol into conical polypropylene tubes. The eluate was evaporated 
to dryness by means of a nitrogen gas stream at room temperature and the residue 
was stored at -20oC.  
We have characterized the performance of the AngII assay in pilot experiments 
where we spiked AngII in the sample before the measurements (data not shown). 
These experiments show that the assay recovers 85% of the AngII peptide in blood 
plasma. As well we find that the detection of the AngII signal is linear for the range 
between 2 and 100 pg/ml. 
 
AngII was assessed with a commercially available AngII enzyme immunoassay kit 
(SpiBio, Montigny Le Bretonneux, France) according to the manufacturer’s 
instructions. The characterization of this kit performance has been published 
(Volland et al. 1999). Briefly, the plasma samples were incubated with 100 l of EIA, 
50 l, 100 l of borane-trimethylamine and with 100 l of anti-AngII IgG tracer. 
Samples were incubated with 200 l of Ellman’s reagent. The plate was red with a 
single quick read on an Absorbance Microplate Reader (ELx800, BIO-TEK) with 
wavelength 405 after 30 minutes, 1 hour and 2 hours of incubation. 
 
ACE Genotyping    
DNA was extracted from mucosal samples using a custom designed protocol. The 
mucosal mouth swabs were extracted with 800 l of methanol with vortexing and 
left to evaporate in air under a stream of nitrogen gas. The pellet was resuspended 
in 100 l of sterile water and stored at -20oC.  
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ACE genotyping was carried out with Polymerase chain reaction (PCR) as described 
by Evans et al. (1994). PCR reactions were run with a mix of the three primers using 
Sybr Green master mix (Applied Biosystems) on a Applied Biosystems Real Time PCR 
system (SepOnePlus, Life Technologies). This involved 45 standard cycles of 
denaturing at 95ºC for 15 s followed by annealing and extension at 55ºC for 1 min. 
Amplicon identification followed using a melting curve analysis between a 
temperature range of 70ºC to 80ºC. The identity of the amplified sequence for the 
ACE-I and ACE-D genotype was validated by sequencing of the PCR products with 
the specific primers (Microsynth, Balgach, Switzerland). The presence of the short 
amplicon for the I-allele was identified by a lower melting temperature (73.5oC; 72.5 
- 74oC) compared to the longer D-allele (75.5oC; 74.5 - 76.5oC) respectively. 
Statistics 
 
Results are mean ± SEM. For AngII the data was logarithmic transformed and an 
analysis of variance (ANOVA) with repeated measures was used to compare time 
and exercise intensity overall and between the ACE genotypes. To compare the 
effect of exercise among ACE genotypes, AngII levels were background-corrected 
and related to the mean values of the respective genotype before exercise. For 
capillary parameters, capillary recruitment and percentage capillary recruitment were 
compared by a Student’s paired t-test. 
Results 
 
Subject (n=10) characteristics at baseline and during the three tests are reported in 
table 1a and 1b. Four subjects carried the ACE-II allele, and six the ACE-ID/DD 
allele. 
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Blood samples data are shown in figure 1 and 2. No correlation was found between 
the blood lactate levels and the serum AngII levels. All indices of metabolic strain, 
i.e. VO2peak, RER, heart rate and lactate levels after exercise were elevated after all 
the three exercise tests and remained high over the study period (figure 1, table 1). 
The highest increases in indices of metabolic strain were observed after the maximal 
test. 
There was a difference in AngII levels before the exercise. AngII levels before the 
first tests at maximal intensity were higher than after the tests done in the course of 
the next days. AngII levels were significantly increased after the 3-minutes exercise 
test (figure 2) but not after the 12-minutes and maximal test. A main effect of the 
presence of the I-allele was identified for the course of changes in AngII levels 
relative to baseline after exercise in the maximal test (p=0.041), but not the 3-
minutes (p=0.357) and 12-minutes test condition (p=0.395). Subjects with the II 
genotype showed a maintained level of AngII whereas AngII levels decreased in 
subjects lacking the I allele after the maximal test (figure 3).  
Table 2 shows a non-significant increase in capillary recruitment in subjects carrying 
the ACE II-allele while a trend for a decreased capillary recruitment after exercise 
was observed in subjects carrying the ACE-ID/DD allele. When we compared the 
genotypes we observed that capillary recruitment after exercise was significantly less 
in the ACE-ID/DD group compared to the ACE II-allele. No indication for an effect for 
capillary recruitment post exercise was seen in function of the I-allele (data not 
shown). 
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Figure 1: Metabolic strain of the three exercise conditions 
Mean + SEM of serum lactate levels at the measured time points post exercise.  
* significantly different from 12-minutes test and 3-minutes test (p<0.01),  
+ significantly different from maximal test and 3-minutes test (p<0.01),  
† significantly different from pre , 0-minutes post and (if measured) 9-minutes post 
(p<0.05). (repeated measures ANOVA, n=10). 
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Figure 2: Serum AngII levels after exercise. 
Mean + SEM of AngII concentration in capillary blood (serum) at the measured time 
points post exercise. * significantly different from 12-minutes test and maximal test 
(p<0.05) and + indicates significantly different from 12-minutes test, maximal test 
and 3-minutes post (p<0.05); (repeated measures ANOVA, n=10). 
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Figure 3: ACE I/D dependence of AngII levels after the maximal exercise test  
Mean + SEM of AngII concentration in capillary blood serum for carriers and non-
carriers of the ACE I-allele. * indicates significant different from the I-allele and from 
no I-allele (pre) p<0.05 (repeated measures ANOVA, n=10)
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 Table 1a: Baseline characteristics of the studied subjects. 
Age 
(year) 
29.6 ± 2.1 
Length 
(cm) 
180.9 ± 7.6 
Mass 
(kg) 
76.1 ± 5.6 
Resting heart rate 
(beats/min) 
65.8 ± 9.0 
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Table 1b: Physiological characteristics of the studied subjects during the three exercise tests. 
  Power 
(watt) 
Heart rate 
(beats/min) 
VO
2
 
(ml O2/min) 
VO
2
/kg 
(ml O2/kg/min) 
RER 
 
RPE 
(6-20) 
Heart 
rate 
before 
exercise 
(beats/min) 
Time after 
last exercise 
test 
(days) 
Peak (last 30 sec) 353 ± 49 187.4 ± 7.4 3885.2 ± 
508.9 
51.0 ± 4.8 1.32 ± 0.07  70.8 ± 3.0  
 Maximal test             AT 215 ± 54 143.9 ± 12.6 2701.8 ± 
604.9 
35.4 ± 6.5   
RCP 301 ± 51 161.3 ± 8.3 3387 ± 
482.7 
44.24 ± 4.6 
12 min test (last 30 sec) 230 ± 48 157.4 ± 5.2 3173.1 ± 
527.4 
41.6 ± 5.3 1.04 ± 0.03 14.3 ± 0.9 73.8 ± 3.5 5.0 ± 0.9 
(range: 2-9) 
3 min test (last 30 sec) 310 ± 42 171.7 ± 9.0 3589.6 ± 
458.3 
47.14 ± 4.5 1.22 ± 0.07 16.6 ± 0.8 69.9 ± 4.0 8.0 ± 1.5 
(range: 2-15) 
VO2 =oxygen uptake, RER = respiratory exchange ratio, RPE = rate of perceived exertion
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Table 2: Capillary recruitment in numbers and percentages before and after the 
maximal test. 
Genotype Test Pre Post p 
II Capillary recruitment (%) 35.5 ± 5.5 43.3 ± 4.6 0.73 
 Capillary recruitment 18.3 ± 2.6 26.8 ± 2.2 0.11 
ID/DD Capillary recruitment (%) 36.2 ± 6.3 23.8 ± 4.1 0.08 
Capillary recruitment 15.9 ± 2.7 12.9 ± 2.4† 0.19 
Values are means ± SEM. † Signiﬁcantly different from capillary recruitment II at 0 min post 
(p<0.05) 
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Discussion 
 
We aimed to detect changes in human AngII levels after exercise at different 
intensities.  
The measured Ang II levels are in line with the values in the seminal report on how 
to measure Ang II in plasma and which identifies that the true levels in serum are 
close to 7-10 pg/ml (Nussberger et al. 1986). Overall it was observed that highest 
increases in indices of metabolic strain were observed after the maximal test. We 
hypothesized that the rise in AngII is dependent on exercise intensity and duration. 
A two fold increase in serum AngII concentration after intense exercise was found 
after the 3-minutes exercise test. This is comparable to the increase found in the 
study of Fagar et al. (1985). No significant increases in AngII were found after the 
12-minutes test and maximal test with also no significant differences in AngII levels 
between the different time points after exercise. (Fig. 2).  
As hypothesized the AngII values after the maximal exercise test were higher in the 
subjects carrying the ACE-II genotype. Subjects without the I allele showed a 
decrease in AngII values after the maximal test where people with the ACE-II 
genotype did not (Fig. 3). A main effect of the presence of the I-allele was identified 
for the course of changes in AngII levels relative to baseline after exercise under the 
maximal test, but not the 3-minutes and 12-minutes test condition. This might 
support a role of the duration of exercise for affecting serum AngII. We therefore 
conclude that the rise in AngII post exercise might be duration dependent and 
seems to be intensity and ACE genotype dependent.  
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It was further observed that as hypothesized subjects with the ACE-II genotype had 
a significant higher capillary perfusion in the finger after exercise compared to the 
ACE-ID/DD genotype. With a trend for a lower capillary perfusion in the ACE-ID/DD 
genotype post exercise, these data indicate that this body compartment is less 
perfused due to AngII dependent vasoconstriction during exercise. This mechanism 
is comparable with the study of Santana et al. (2011) in which they found a main 
effect in systolic blood pressure between the ACE genotypes after a maximal test 
and a cycling test at 90% AT. They also showed a protective effect on post-exercise 
diastolic blood pressure and MAP. The initial vasoconstriction may be overridden by 
maximal cycling exercise due to the systemic action of released nitric oxide (NO) and 
adenosine (Santana et al. 2011). We therefore conclude that there seems to be a 
relationship between AngII levels and ACE genotype and between ACE genotype and 
blood flow. 
It was astonishing that a difference was noted for AngII levels at rest before each of 
the three tests (Fig. 2). We note that the values measured for AngII (see Fig. 2) are 
in the range of reported values (i.e. 2.3-18.6 pmol l-1; Ueda et al. 1998). It has 
been reported that exercise lowers hypertension and that this effect lasts certainly 
13 hours (Kenney and Seals 1993). Santana et al. (2011) showed that only people 
with the I allele of the ACE genotype had post exercise hypotension and increased 
NO-release. As AngII levels in serum relate to blood pressure (Kaplan and Silah 
(1964) and the 3-minutes tests were by some subjects conducted 2 days after the 
maximal test, including subjects bearing the I allele the hypothesis is raised that the 
lowered AngII may be related to post exercise hypotension that lasts at least 15 
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hours (Kenney and Seals 1993). The heart rate before the 3 minutes test was non-
significant higher, compared to the maximal test (table 1b). 
Remarkable is also the variation in AngII levels between the subjects that can be 
revealed from the standard error (Fig. 2). Subjects with the ACE-II genotype had 
significant higher AngII values at all the time points after the maximal test then 
people without the I allele, who demonstrate decreased AngII values after the 
maximal test (Fig. 3). On the identified effect of ACE genotype on the AngII levels 
after the maximal test, we think the ACE genotype exerts a major influence on the 
standard error. These results indicate that the D-allele restricts production of AngII 
after exercise, while people without a D-allele maintain AngII levels after exercise.  
 
A limitation of our study was that capillary recruitment measurements were only 
performed at the maximal test. Due to the short duration, we expect no exercise 
induced vasodilatation based on literature after the 3 minutes cycling test 
(Tschakovsky et al. 2002). Therefore we cannot rule out that for instance the 
increase in serum AngII immediately after the 3-minuts test is an acute phenomenon 
of vasoconstriction in non-exercised body parts that also took place in subjects 
exercising for longer duration and which did not halt exercise to allow sampling of 
this time point.  
 
The increase in AngII levels after exercise causes the blood pressure to decrease but 
on the other hand it is expected to promote angiogenesis in the activated muscles 
by activating the endothelial cell population that constitutes the capillary wall 
(Brothers et al. 2006). A trend was observed that subjects with the ACE-DD/ID 
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polymorphism showed a decrease in capillary recruitment after exercise. Subjects 
with the ACE-II polymorphism had a significant larger recruitment of the relative 
capillaries after exercise compared to subjects with the ACE-ID/DD polymorphism. 
The rise in serum AngII with the 3-minutes exercise protocol at the RCP highlights a 
role of high intensity exercise for a short duration. Taking into account that the 
maximal test also included a similar level of intensity we analyzed the role of 
exercise time of exercise-induced systemic vasodilatation. The identified decrease in 
capillary recruitment in the finger of ACE-ID-DD genotypes after the maximal test 
supports the contention of an elevated potential for vasoconstriction in non-
exercised body parts in subjects which do carry the D-allele. In this regard the 
documented increase in ACE transcript expression in vastus lateralis muscle being 
recruited during bicycle exercise in ACE-DD genotypes (Vaughan et al. 2013) 
suggests a role of the ACE I/D polymorphism in controlling capillary recruitment with 
exercise via effects on ACE gene expression.  
The data indicate that variability in the response of the major vasoconstrictor, AngII, 
in serum after exercise is ACE genotype-dependent and not related to blood lactate 
levels. In some contradiction to Danser et al. (2007) we see that in the controlled 
situation of maximal exercise, there is evidence for a role of the ACE I/D 
polymorphism in explaining variability in serum AngII and capillary perfusion. Thus, 
physical activity must be considered as an important confounder of previous 
conclusions. Awareness of the differences in AngII generation after exercise could 
have clinical repercussions on current Health Care practice. It may be one of the 
reasons why people with the ACE-II genotype and/or people taking ACE inhibitors 
show lowered gains as a result of exercise rehabilitation (Defoor et al. 2006).  
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Abstract 
 
Skeletal muscle responds to endurance exercise with a improvement of biochemical 
pathways that support substrate supply and oxygen dependent metabolism. This is 
reflected by enhanced expression of associated factors post exercise and appears to 
be specifically modulated by tissue perfusion and oxygenation. We hypothesized that 
transcript expression of pro-angiogenic factors (VEGF, Tenascin-C, Angpt1,Angpt1R) 
and oxygen metabolism (COX4I, COX4I2, HIF-1α) in human muscle after an 
endurance stimulus depends on vasoconstriction, and would be modulated through 
inhibition of ACE by intake of lisinopril.  
Fourteen non-specifically trained, male Caucasians subjects, carried out a single bout 
of standardized one-legged bicycle exercise. Seven of the participants consumed 
lisinopril in the three days before exercise. Biopsies were collected pre- and three 
hours post-exercise from the m. vastus lateralis. COX4I1 (p=0.03) and HIF-1α 
(p=0.05) and COX4I2 (p=0.04) mRNA levels showed an exercise-induced increase in 
the group not consuming the ACE inhibitor. Conversely, there was a specific 
exercise-induced increase in transcript levels for the pro-angiogenic factor VEGF 
(p=0.04) and a trend for increased Tenascin-C transcript levels (p=0.09) for subjects 
consuming lisinopril. The observations indicate that regulation of exercise-induced 
transcript expression of genes involved in angiogenesis and mitochondrial energy 
metabolism are to some extent regulated via an ACE-dependent mechanism. 
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List of abbreviations 
ACE(i): Angiotensin converting enzyme (inhibitor) 
AngII: Angiotensin II 
Angpt1(R): Angiopoietin 1 (receptor) 
ATP : Adenosine triphosphate  
COX4I1: Isoform 1 for subunit 4 of cytochrome c oxidase 
COX4I2: Isoform 2 for subunit 4 of cytochrome c oxidase 
(c)DNA: (Complementary) deoxyribonucleic acid 
DMSO: Dimethyl sulfoxide 
EDTA: Ethylenediaminetetraacetic acid 
EIA: enzyme immunoassay 
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase  
HCL: Hydrochloric acid 
HIF-1(α): hypoxia-inducible factor (α-subunit) 
PCR: Polymerase chain reaction 
(m)RNA: (Messenger) ribonucleic acid 
rpm: revolutions per minute 
VEGF: Vascular endothelial growth factor  
VO2-peak: maximal oxygen uptake 
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Introduction 
 
Exercise causes intensity-dependent vasodilation and increases blood flow to 
contracting muscles (Andersen and Saltin 1985), ensuring an adequate oxygen 
supply to the contracting muscle. This exercise hyperaemia is challenged by 
activation of sympatho-adrenergic and nonadrenergic vasoconstrictor systems. After 
mild and moderate intense exercise there is an exercise-induced inhibition of AngII-
induced vasoconstriction indicating that muscle contractions attenuate adrenergic 
and non-adrenergic vasoconstriction. During severe exercise there is a higher 
sympathetic activity and an increase in the activity of plasma rennin and a 
subsequent increase in the production of ACE and vasoconstrictor angiotensin II 
(AngII) is observed (Staessen et al. 1987). During increasing intensities of exercise 
the concomitant increasing activity in sympathetic vasocontrictor nerves is driven by 
a combination of central nervous coactivation of motor control and sympathetic 
outflow and muscle-derived afferents (Victor et al. 1995). 
There is evidence that the role of AngII in stimulating angiogenesis relies on 
capillary perfusion of skeletal muscle (Petersen et al. 2007). AngII elevates arterial 
pressure because of its vasoconstrictor action and restricts blood from entering non-
active muscles in order to direct blood flow to active tissues with enhanced energy 
turnover (Andersen et al. 1985). The AngII-mediated vasoconstriction is overridden 
with the onset of contraction through flow-mediated dilatation of conduit arteries 
and arterioles and promotes angiogenesis by activating the endothelial cell 
population that constitutes the capillary wall (Brothers et al. 2006; Hahn et al. 
1995).  
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Training increases the capacity for aerobic ATP production in skeletal muscle through 
an elevation in the volume density of mitochondria in untrained subjects (Hoppeler 
et al. 1985). After cycling exercise under lowered ambient oxygen (hypoxia ) there is 
a larger increase in the volume density of subsarcolemmal mitochondria compared to 
those residing between myofibrils, indicating that local adaptations are specifically 
modified by the amount of oxygen in the muscle during exercise (Desplanches et al. 
1993; Schmutz et al. 2010; Vogt et al. 2001). As a result there are improvements in 
maximal oxygen uptake (VO2-peak), aerobic power, fatigue resistance and also in 
subsarcolemmal mitochondria after trainingin hypoxia compared to normoxia 
(Hoppeler et al. 1992; Ponsot et al. 2006; Zoll et al. 2006; Flück et al. 2006).  
Metabolic and vascular adaptations that may be involved in the hypoxia-specific 
improvement of muscle specific aerobic capacity after repeated endurance workouts 
include the enzymes operating at critical biochemical steps of mitochondrial 
respiration under lowered muscle oxygenation during severe exercise in hypoxia 
(Flueck et al. 2009; Richardson et al. 1995). One of the key metabolic enzymes is 
cytochrome c oxidase, which is the last enzyme in the respiratory electron transport 
chain converting molecular oxygen to water. After one bout of intense bicycle 
exercise under hypoxia isoforms 1 and 2 of oxygen-sensitive cytochrome c oxidase 
(COX4I1, COX4I2) plays a role in the enhancements of the aerobic capacity (Flueck 
et al. 2009; Richardson et al. 1995). After exhaustive endurance exercise in hypoxia 
the expression of COX4I2 is elevated more than the isoform COX4I1 (Fukuda et al. 
2007). A correlation between elevated COX4I2 transcripts post exercise and the 
increased volume density of subsarcolemma mitochondria after thirty repetitions of 
64 
 
the exercise stimulus with training supports that transcript expression post exercise 
reflects exercise induced mitochondrial plasticity (Desplanches et al. 2014).  
Another important factor, vascular endothelial growth factor (VEGF), causes 
increases in vascular permeability, endothelial cell proliferation, and angiogenesis. 
Breen et al. (1996) showed that mRNA levels of angiogenic growth factors such as 
VEGF in the gastrocnemius of rat were significantly increased after a bout of 
endurance exercise. The same was found after a period with chronic electrical 
stimulation during exercise (Hang et al. 1995) indicating that muscle activity leads to 
an increase in mRNA levels for angiogenic growth factors. The findings support the 
notion that transcript level alterations in skeletal muscle after a single bout of 
endurance exercise are a proxy for the subsequent adaptations with repetition of an 
endurance stimulus (Desplanches et al. 2014; Flück et al. 2006).  
Muscle transcript expression after endurance exercise is graded with regard to 
metabolic stress and modulated by oxygenation (Schmutz et al. 2010). We 
hypothesized that the exercise-induced alteration in expression of genes of pro-
angiogenic and oxygen-dependent factors are modulated by ACE activity due to its 
influence on muscle perfusion (Brothers et al. 2006). We assumed that pro-
angiogenic factors such as VEGF, Tenascin-C, Angpt1 and Angpt1R are increased 
post exercise while oxygen-dependent factors such as COX4I, COX4I2 and HIF-1α 
are blunted after exercise in subjects taking an ACE inhibitor. This was tested in 
biopsies of knee extensor muscle within 3 hours after a single bout of bicycle 
exercise. 
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Methods   
 
Experimental design 
The study has been approved by the ethics board of the Manchester Metropolitan 
University. Written informed consent was obtained from every participant. 
To test our hypothesis we carried out a pharmacological intervention with humans 
that were characterized anthropometrically. Fourteen Caucasian male subjects, non-
specifically trained, took part in the study carrying out a maximal exercise test to 
characterize aerobic fitness and a single bout of one-legged exercise where we 
collected muscle and blood samples.  
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Table 1: Participants details. Charataristics of the participants in the ACE inhibition 
and control group. Values are mean ± SEM. 
 ACE inhibition group Control group 
Age (years) 30.3 ± 2.72 23.3 ± 1.33 
Height (m) 1.76 ± 0.04 1.80 ± 0.02 
Mass (kg) 75.4 ± 4.6 72.33 ± 2.87 
Exercise (h/week) 10.4 ± 1.83 3.2 ± 0.63 
VO2-peak (l/min) 
(2-legged test) 
3.72 ± 0.74 3.65 ± 0.32 
VO2-peak (l/min) 
(1-legged test) 
3.28 ± 0.21 3.15 ± 0.62 
Blood pressure at rest (mm HG) 
Systolic 130.8 ± 7.1 118.9 ± 1.75 
Diastolic 71.4 ± 4.1 71.4 + 1.70 
Systolic after ACE 
inhibition 
129.8 ± 4.1   
Diastolic after ACE 
inhibition 
69.6 ± 3.5   
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Anthropometric characterization 
In an entry test peak VO2-peak was established with a maximal exercise test and 
subjects height and mass were measured. A mucosal mouth swab to establish the 
ACE genotype was taken by twirling/rubbing an ear bud against the inner cheek 
wall. Blood pressure was measured in a calm place in seated position with a 
sphygmomanometer after the subject has been sitting for at least 15 minutes. Seven 
of the participants were asked to consume daily an ACE inhibitor (ACE inhibition 
group: Lisinopril, 10 mg/day, Zestril, AstaZeneca) in the morning for three days 
including the day of the exercise test, the other group (control group) was not asked 
to use the ACE inhibitor. On the testing day subjects reported fasted to the 
laboratory and performed a single-leg standardized exercise test. Venous blood and 
a biopsy sample from vastus lateralis muscle were collected by a physician (SW). 
Blood collection was done via venipuncture from the upper arm before and 
immediately after the bout of exercise, while the subjects were in a sitting position. 
5ml of blood was drawn from the Cephalic vein into a tube sprayed with dry EDTA 
(K2E BD Vacutainer, Belliver Industrial Estate, Phymouth, UK) placed on ice. A 2ml 
aliquot was rapidly processed for the measure of AngII. 
Biopsies were collected under local anesthesia (subcutaneous injection of 1ml 2% 
Lidocaine) before and 3 hours post exercise from the belly portion of vastus lateralis 
muscle with a needle device (TSK Acecut 11G, UK biopsy).  
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Exercise tests 
Maximal test 
Two-leg exercise aerobic capacity was measured with ergospirometry during a 
cycling exercise test on an Excalibur bicycle (Lode Groningen, The Netherlands). 
Expired air was measured breath by breath (Oxycon alpha, Jager GmbH, Wurzburg, 
Germany) and heart rate using a heart rate belt (Accurex Plus, Polar Electro Finland, 
Kempele, Finland). The test started at 40 Watt and subjects were asked to cycle at 
80 revolutions per minute (rpm). The power was increased every two minutes with 
30 watts until the subject could no longer maintain a cadence higher than 60 rpm 
with verbal support. 
 
One-legged exercise test 
Subjects completed the one leg exercise test with their dominant leg and the shoe 
taped with duct tape to the pedal on an Excalibur bicycle (Lode Groningen, The 
Netherlands). The protocol of the exercise test was a 3 minutes warm-up at 50 
Watt, followed by 25 minutes at 1.2-times body mass in Watts and ending with a 
ramp up of 10 Watt/min until exhaustion. See figure 1 for the characteristics of the 
stimulus. The subjects cycled at a cadence of 80 rpm and the test ended when in 
the last phase the cadence dropped below 60 rpm. This protocol was chosen to 
maximize the metabolic stimulus for recruited muscle groups, without central 
aspects posed a limitation that may interact with the systemic effects of ACE activity 
on blood pressure and perfusion.  
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Figure 1: One-legged exercise. Line graph depicting the characteristics of the one-legged exercise stimulus. Oxygen uptake 
(continuous line) and the work rate during the warm-up, constant load, and ramp phases (stippled line) are shown. A clear peak of 
intensity can be identified.  
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ACE genotyping 
DNA was extracted from mucosal samples using a custom designed protocol. The 
mucosal mouth swabs were extracted with 800 l of methanol with vortexing and 
left to evaporate in air under a stream of nitrogen gas. The pellet was resuspended 
in 100ml of sterile water and stored at -20ºC.  
ACE genotyping was carried out with Polymerase chain reaction (PCR) as described 
by Evans, (1994). The primers corresponded to those established previously for the 
identification of the ACE-I/D genotype (for details see Genbank number X62855): 
detection of the 83-bp-amplicon specific to the absence of the insertion sequence 
(i.e. the D-allele) was achieved by a combination of ACE1 (5’-catcctttctcccatttctc-3’) 
and ACE3 (5’-atttcagagctggaataaaatt-3’) primers. ACE2 (5’-tgggattacaggcgtgatacag-
3’) and ACE3 (5’-atttcagagctggaataaaatt-3’) primers were applied to detect the 66-
bp-amplicon specific for the I-allele in intron 16 of the ACE gene . 
PCR reactions were run with a mix of the three primers using Sybr Green master mix 
(Applied Biosystems) on a Applied Biosystems Real Time PCR system (SepOnePlus, 
Life Technologies). This involved 45 standard cycles of denaturing at 95ºC for 15 sec 
followed by annealing and extension at 55ºC for 1 min. Amplicon identification 
followed using a melting curve analysis between a temperature range of 70ºC to 
80ºC. The identity of the amplified sequences was validated by sequencing of the 
PCR products with the specific primers (Microsynth, Balgach, Switzerland). 
Subsequently, the presence of the short amplicon for the I-allele was identified 
based on a lower melting temperature (73.5ºC; 72.5 - 74ºC) compared to the longer 
D-allele (75.5ºC; 74.5 - 76.5ºC) respectively. 
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Assessment of AngII levels 
Blood (2 ml) was withdrawn from the venous cannula into vacutainers containing 
60μl AngII inhibitor cocktail, comprising 13.35μl of O-Phenanthroline and Pepstatine 
A in DMSO mixed with 46.65μl of EDTA and PHMB in aqueous solution (SPI bio, 
Bertin pharma, Versailles, France). The samples were immediately centrifuged at 
10,000 rpm (3,000 g) and 4ºC for 12 min. The supernatant was separated, snap 
frozen in liquid nitrogen and stored at -80ºC until analysed. Plasma was extracted 
with C18 phenyl cartridge which were conditioned with 2ml of methanol and then 
rinsed with 2ml of water. Cold plasma (0.9ml) was rapidly passed through the 
cartridge and subsequently washed with 1ml of water. Absorbed angiotensins were 
eluted with 1ml of methanol into conical polypropylene tubes. The eluate was 
evaporated to dryness by means of a nitrogen gas stream at room temperature and 
the residue was stored at -20oC. AngII was assessed with the AngII enzyme 
immunoassay kit (SpiBio, Montigny Le Bretonneux, France). Briefly, the plasma 
samples were incubated for 1 hour with 100μl of EIA buffer (reconstituted the EIA 
buffer vial with 50ml of distilled water), for 5 minutes with 50μl of glutaraldehyde 
4.878ml of distilled water), for 5 minutes with 100μl of borane-trimethylamine 
(borane-trimethylamine vial diluted in 2.5ml of 2N HCL and 2.5 ml of methanol) on a 
rocker platform, and with 100μl of anti-AngII IgG tracer (reconstituted the anti-
antiotensin II-IgG tracer in10ml of EIA buffer) at 4o overnight. On the next day the 
samples were incubated with 200μl of Ellman’s reagent (Ellman’s reagent vial in 1ml 
of concentrated Wash buffer and 29ml of distilled water). The plate was run with a 
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single quick read on an Absorbance Microplate Reader (ELx800, BIO-TEK) with 
wavelength 405 after 30 minutes, 1 hour and 2 hours of incubation. 
After plotting the absorbance of each standard point versus the concentration, the 
AngII concentrations were calculated by interpolating from this standard curve. In 
order to reduce variability, AngII values were normalized by dividing every value by 
the median of the pre values. 
Transcript measures  
Total RNA was isolated from 10mm3 of biopsy samples in 20um sections using an 
RNeasy mini kit (Qiagen, cat No 74101) and Proteinase K (Qiagen, cat No 19131) as 
described by Schmutz et al. (2010). Concentration and quality of RNA were 
determined using a NanoDrop USV-99 AGTGene (Labgene Scienfitic SA, 
Switzerland). 
cDNA was reverse transcribed from 600 ng of RNA using a OMNIscpript Kit (Qiagen, 
cat No 205110) with random hexameres according to the manufactures’ instructions. 
RT-qPCR was carried out for 8 candidate genes (Tenascin-C, COX4I1, COX4I2, HIF-
1α, Angpt1, Angpt1R, VEGF,  and GAPDH) and the reference gene for normalization 
(28S r RNA). cDNA corresponding to an estimated input of 0.6ug (0.06ug for 28s) 
was dispensed into each well with a final reaction volume of 10ul. Pooled primer 
pairs (200nM each) and KAPASSybr FAST Master MIX 2X (Kapa Biosistems, KK4600) 
were performed on EcoTM Thermal and Optical system (Illumina, Labgene Scientific 
SA, Switzerland). Primer sequences for each gene are listed in Table 2. Each sample 
was amplified in duplicate using the following conditions: preheating at 95ºC for 2 
minutes, followed by 45 cycles at 95ºC for 15 seconds ant 60ºC for 1 minute. The 
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calculation of transcript amounts were analyzed with the ΔCT method but taking the 
individual efficiency into account. The resulting values were standardized to those of 
28S.  
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Table 2. Summary of the reference genes and Primers sequence. 
Primer Sequences 
28S rRNA Forward Primer: 5’ATA TCC GCA GCA GGT CTC CAA-3’ 
Reverse primer: 3’-GAG CCA ATC CTT ATC CCG AAG-5’ 
COX-1 Forward Primer: 5’-CTA TAC CTA TTA TTC GGC GCA TGA -3’ 
Reverse Primer: 3’-CAG CTC GGC TCG AAT AAG GA-5’ 
COX-4I1 Forward Primer: 5’-GCC ATG TTC TTC TTC ATC GGT TTC-3’ 
Reverse Primer: 3’-GGC CGT ACA CAT AGT GCT TCT G-5’ 
HIF-1α Forward Primer: 5’-TAG TGA ACA GAA TGG AAT GGA GCA A-3’ 
Reverse Primer: 3’-TTT TTG GAC ACT GGT GGC TC5’ 
Angpt1 Forward Primer: 5’-CGC TGC CAT TCT GAC TCA CAT A-3’ 
Reverse Primer: 3’-CGG TTA TAT CTT CTC CCA CTG TTT TC-5’ 
Angpt1R Forward Primer: 5’- GTT GGC CTT TCT GAT CAT ATT GC-3’ 
Reverse Primer: 3’-GGT TCT TCC CTC ACG TTT TGG-5’ 
Tenascin-C Forward Primer: 5’-TAC CAA AAA GCA GTC TGA GCC ACT GGA AAT 
AAC CCT ACT TGC CCC CGA ACG TAC CAG GGA CAT AAC AGG TCT 
CAG AGA GGC TAC TGA ATA C-3’ 
Reverse Primer: 3’-CAT AAG TCA TCG GAG AGA CTC TGG ACA ATT 
CAG GGA CCA TGC AAG CCC CCG TTC ATC CCA ATA AAG GTC ACC 
GAG TCT GAC GAA AAA CCA T-5’ 
VEGF Forward Primer: CAT GGC AGA AGG AGGAGG GCA GAA TCA 
Reverse Primer: ATC TTC AAG CCA TCC TGT GTG CCC CTG 
GAPDH Forward Primer: 5’-GGA GCG AGA CCC CAC TAA CA-3’ 
Reverse Primer: 5’-GCC TTC TCC ATG GTG GTG AA-5’ 
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Bp, base par; PCR, Polymerase Chain Reaction; HIF-1α, Hypoxia-Inducible Factor-
1a; COX, cytochrome C oxidase; Angpt, angiopoetin; VEGF, Vascular Enothelia 
Growth Factor; GPDH, glyceraldehydes-3-phosphate dehydrogenase 
Statistics 
 
Data were organised in MS-Excel and exported into SPSS 19.0 for statistical testing. 
Differences in blood pressure and AngII were analyzed with a paired samples t-test. 
Pre/post changes and fold changes in transcript expression of COX4I1, COX4I2, HIF-
1α, Angpt1 and Angpt1R between the ACE inhibition group and control group were 
assessed with a multiple analysis of variance and a two-factor ANOVA 
respectively.Significance of a difference was declared at p<0.05.  
 
Results 
 
The ACE genotypes of the subjects: ACE inhibition group (ACE-DD: 5, ACE-ID/II: 7); 
control group (ACE-DD: 5, ACE-ID/II: 1). Anthropometry (mass, height, age), 
VO2max and resting blood pressure of the subjects of the two groups did not differ 
significantly (Table 1). There was no difference in systolic (p=0.16) or diastolic blood 
pressure (p=0.94) between the study groups. Intake of ACE inhibitor did not affect 
systolic (p=0.90) or diastolic (p=0.73) blood pressure at rest (Table 1). 
There was a trend for an effect for the intake of ACE inhibitor on the fold changes in 
transcript expression post exercise (p=0.09, figure 2). Fold changes in transcript 
expression in the vastii was significantly higher 3 hours post exercise in the control 
group for COX4I2 (p=0.03) and HIF-1α (p=0.05). The level of COX4I2 was 
increased 3 hours post exercise in the control group (p=0.04) but not in the ACE 
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inhibition group (p=0.91). Fold changes in transcript expression post exercise was 
significantly larger in the absence of ACE inhibitor intake of the pro-angiogenic 
transcript VEGF (p=0.04). A trend for such an effect was seen for Tenascin-C 
(p=0.09). 
AngII levels were 1.6 times and glucose 1.20 times significantly increased after 
exercise under oral intake of ACE without significant increases in the control group 
(see table 3). 
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Figure 2: Transcript expression in the vastii 3 hours post exercise with or without oral intake of ACE inhibitor. AngPo: Angiopoietin 
1; COX4I1: Isoform 1 for subunit 4 of cytochrome c oxidase; COX4I2: Isoform 2 for subunit 4 of cytochrome c oxidase; GAPDH: 
Glyceraldehyde 3-phosphate dehydrogenase; HIF-1α: hypoxia-inducible factor α-subunit; VEGF: Vascular endothelial growth 
factor. * and † denote significant difference (p<0.05 ) andtrend (0.05  p<0.10; Repeated measures ANOVA).
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Table 3: AngII and glucose levels pre and post exercise and the fold increases.  
 Group Pre  Post Fold 
AngII values 
(pg/mol) 
ACE 
inhibition 
 17.4 ±3.7 25.0  ±3.9 1.6† ±0.4 
 Control 15.2 ±3.7 18.2 ±2.2 1.7 ±0.4 
Glucose 
(mmol/l) 
ACE 
inhibition 
2.33 ±0.13 2.85* ±0.19 1.20† ±0.53 
Control 4.70 ±0.48 4.63 ±0.76 1.02 ±0.20 
Values are mean ± SEM paired samples t-test. * denotes significant different from 
pre ACE inhibition (p<0.05), † denotes significant increase post exercise (p<0.05).  
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Discussion 
 
Three hours after exhaustive cycling exercise the pro-angiogenic factor VEGF and 
Tenascin-C were increased in the ACE inhibition group, but not in the control group.  
Also in the study of Gavin et al. 2000 they found VEGF mRNA expression both in the 
group who took the first generation ACE inhibitor captopril as in the control group 
after an hour of moderate intense exercise (≈50% VO2-max). In that study the post 
exercise VEGF levels were not significantly different from the group that took the 
placebo. 
Flueck (2009) reviewed that endurance training under hypoxia enhances the 
structural components of local aerobic capacity by increasing mitochondrial protein 
expression. The low intramuscular oxygen levels in the muscle in combination with 
contraction-related signals are the driving force for angiogenic and mitochondrial 
protein expression with endurance training. Involvement of signaling to muscle 
remodeling with low oxygen content with exercise is illustrated by the modulation of 
the master regulator of hypoxia-regulated gene expression, the dimeric transcription 
factor HIF-1 (Semenza et al. 2004). Hypoxia-dependent regulation by HIF-1 is 
turned off in well- oxygenated conditions by the degradation of its alpha-subunit, 
HIF-1α. When the hypoxia drops to a critical level, HIF-1α is stabilized (Flueck et 
al. 2009). In our study HIF-1α transcript levels were increased in the control group, 
while they were blunted in the ACE inhibition group. The same was observed for 
COX4I2. We have reported before that HIF-1α and COX4I2 transcript levels are 
regulated in a hypoxia-modulated manner after two-legged endurance type bicycle 
exercise (Desplanches et al. 2014). Thereby COX4I2 transcript levels were increased 
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24 hours after a single exercise bout at 65% of respective peak aerobic power 
output in ambient hypoxia equivalent to 4,000 m above sea level. Exercise in 
hypoxia produces a pronounced drop in muscle oxygenation (reviewed in 
Desplanches et al. 2014). This emphasizes that enhanced COX4I2 mRNA expression 
in exercised muscle constitutes a marker of local hypoxia (Fukuda et al. 2007). 
These considerations support the notion that the modulation of muscle’s transcript 
regulation by lisinopril is related to muscle oxygenation during exercise. 
The AngII values were 1.6 times higher after exercise in the ACE inhibition group 
and not significantly increased in the control group. This increase in AngII is 
comparable with the study of Fagard et al. (1985). The increase in the ACE inhibition 
group as well as the higher increase in this group compared with the control group 
could indicate an incomplete inhibition of ACE during and after exercise. The 
difference in AngII levels between the two groups can be explained by an 
ACEinhibition at rest and so low AngII levels and an incomplete inhibition during 
exercise. This is supported by the study of Aldigier et al. (1993) where they found a 
higher increase of AngII in the ACE inhibition group during exercise compared to the 
control group. 
The data in this study point at an effect of commonly used anti-hypertensive 
treatment on the muscle response to exhaustive bicycle type endurance exercise and 
supports the view that an angiotensin-regulated mechanism dictates the hypoxia-
specific gene response in peripheral muscle to endurance exercise. Our finding that 
lisinopril increases pro-angiogenic factors associated with the capillaries in the 
interstitium, i.e. VEGF and Tenascin-C (Milkiewicz et al. 2001, Flück et al. 2000) and 
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inhibits the increase in oxygen dependent transcripts which are thought to mainly 
situate in muscle fibres (COX4I2, HIF-1α) indicates that there is a shift in the 
activation of the gene program from muscle fibres to the surrounding interstitium 
under oral intake of ACE inhibitor. As ACE inhibitors in combination with endurance 
type of exercise is widely prescribed to people with hypertension, our findings can 
have ramifications for improving the current anti-hypertensive treatment.  
A limitation of this study is that it is not built on a cross-over design. The absence 
calls for a further study to confirm our findings and expose the functional implication 
of our observation. As this study is based upon a single exercise bout, the protein 
levels corresponding to the measured transcripts (for instance VEGF) were not 
assessed, because protein levels are expected to change as a response to endurance 
training rather than a single exercise bout. 
 
Conclusion and perspective 
 
Exercise-induced alterations in gene transcripts are partly under the control, or 
modulated, by ACE-dependent pathways. This exercise induced mechanism has 
rarely been valued in pharmacological studies of hypertension and exercise 
rehabilitation (Böhm et al. 2008). Awareness of the existence of such a mechanism 
could develop a major impact on current Health Care practice, particularly in the 
situation of exercise rehabilitation when one wants to exploit the sympatholytic and 
angiogenic benefits of physical therapy. This relationship can have major economic 
and clinical repercussions as inhibiting ACE therapies are the current default for 
hypertensive patients.  
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ABSTRACT 
 
Endurance training can increase muscle capillary density in human skeletal muscle. 
We hypothesized that this process depends on capillary adhesion modulation 
through elevated expression of Tenascin-C with exercise-induced vasodilatation. To 
investigate this possibility, we examined whether (I) training-induced capillary 
remodeling in vastus lateralis muscle of healthy, Caucasian, male subjects is affected 
by the single-nucleotide polymorphism (SNP) rs2104772 that is predicted to affect 
Tenascin-C’s adhesive properties due to a thymidine (T)-to-adenosine (A) exchange 
at position 44,513 in the Tenascin-C gene. We further analyzed whether (II) 
Tenascin-C expression in exercised muscle depends on ACE activity and the training 
state, which both increase muscle perfusion capacity. Tenascin-C transcript levels in 
vastus lateralis were elevated 8 hours after exhaustive one-legged bicycle exercise in 
trained (n = 7) but not in untrained subjects (n = 7). Intake of ACE inhibitor 
Lisinopril (n = 7) increased Tenascin-C and VEGF-A transcript levels in untrained 
subjects after the bicycle exercise but failed to reduce blood pressure and exercise-
induced serum angiotensin 2 concentration while increasing ACE activity in muscle. 
Six weeks of bicycle endurance training (n = 36) elevated the concentrations of the 
small (+128%) and large (+77%) Tenascin-C isoform. Likewise, capillary-to-fiber-
ratio (+13%), capillary density (+10%), and mitochondrial volume density (+24%) 
were increased after training in an rs2104772 dependent manner (P < 0.01). 
Capillary-to-fiber ratio was reduced in T/T genotypes (14%). Our findings support a 
role of Tenascin-C expression in the stabilization of capillaries, which depends on 
enhanced angiotensin 2 concentration under concomitant inhibition of 
vasoconstriction during endurance work. 
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INTRODUCTION 
 
Endurance training—i.e., the repeated contraction of skeletal muscle at a 
moderate to high load until fatigue—increases mitochondria and capillary volume 
density, thus improving the myocellular energy supply (Mortensen et al. 2012, 
Wibom et al. 1992, Zumstein et al. 1983). The first weeks of training typically induce 
20–40% increases in capillary and mitochondrial volume density (Hoppeler et al. 
1985). The underlying mechanisms involve metabolic and mechanical factors, 
whereby stimuli that influence extracellular matrix architecture and composition 
seem to pronouncedly impact on capillary density and capillary-to-fiber ratio (Badr et 
al. 2003, Prior et al. 2004). Angiotensin-mediated vasoconstriction limits blood flow in 
resting muscle and must be overcome with the onset of exercise to allow perfusion 
of contracting muscle tissue (reviewed in (Brothers et al. 2006, Clifford et al. 2004, 
Korthuis 2011, Wunsch et al. 2000). Endurance training exerts a positive influence on 
exercise-induced muscle perfusion (reviewed in (Husain et al. 2014, Mortensen et al. 
2014), by improving endothelium-dependent vasodilatation of arterioles and 
capillaries (Korthuis 2011). Collaterally with intense exercise, however, an increase in 
serum angiotensin 2 concentration can be observed, potentially reducing blood flow 
to metabolically-inactive tissues (Brothers et al. 2006, Korthuis 2011, Staessen et al. 
1987) and exerting direct actions on endothelial cells in the perfused capillaries 
(Clapp et al. 2009). The inhibition of angiotensin’s action on arterioles therefore may 
be a main contributor to increasing shear stress to capillary walls, which is believed 
to drive angiogenesis with exercise (Hudlicka et al. 1992) and may conspire with the 
pro-angiogenic action of angiotensin 2 (Clapp et al. 2009). This relationship is 
highlighted by the enhanced muscle capillary density in subjects with increased 
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expression of angiotensin-converting enzyme (ACE), which produces the 
vasoconstrictor angiotensin 2 (Vaughan et al. 2013).  
Studies in rodents show that the anti-adhesive extracellular matrix protein 
Tenascin-C is a mechanoregulated governor of angiogenic gene expression in 
cardiac and skeletal muscle (Ballard et al. 2006, Fluck et al. 2008). Reflecting this role, 
Tenascin-C is expressed in migrating endothelial cells and branching sites of blood 
vessels (Hahn et al. 1995, Jarvinen et al. 2003, Mackie et al. 1992, Mustafa et al. 2012). 
Tenascin-C expression is induced by the vasoconstrictor peptide angiotensin II in 
cultured smooth muscle cells, and is increased in vascular structures in hypertension 
(Mackie et al. 1992, Sharifi et al. 1992), suggesting that Tenascin-C mediates the 
effect of angiotensin II on pathological blood vessel growth. However, this 
hypothesis has never been tested in vivo, particularly as it relates to physiological 
angiogenesis after endurance exercise. Nor has any study characterized whether 
endurance exercise affects other metabolic processes related to capillary growth, 
such as mitochondrial biogenesis, via a Tenascin-C related mechanism. 
Here we used a genetic approach with the aim of identifying the role of 
Tenascin-C in endurance training-induced remodeling of capillary supply lines in the 
knee extensor muscle, as well as the interactions of Tenascin-C with the angiotensin 
converting enzyme. We focused on the single-nucleotide polymorphism rs2104772 
(A/T) in exon 17 of the Tenascin-C gene, which impacts the elastic/adhesive 
properties of Tenascin-C in subjects with the A/A genotype (Matsuda et al. 2005, 
Saunders et al. 2013). We investigated I) whether subjects with the A/A genotype of 
rs2104772 demonstrated a blunted muscle capillary density and capillary-to-fiber 
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ratio response following training, II) whether the identified effects were reflected by 
an altered Tenascin-C expression response to a single bout of endurance exercise 
and, finally, III) whether this response and expression of VEGF-A that is associated 
with contraction-induced angiogenesis through an angiotensin-dependent 
mechanism (Amaral et al. 2001) was influenced by ACE activity.  
 
METHODS 
 
Design  
This study included two groups of white Caucasian subjects. Group 1 
performed a single bout of bicycle exercise with or without oral intake of the ACE 
inhibitor Lisinopril at Manchester Metropolitan University in the United Kingdom. 
Group 2 performed endurance training on a stationary bicycle ergometer at the 
University of Berne in Switzerland. 
Group 1 included 21 healthy, young male subjects of white British descent, 7 
of which were endurance-trained. One week prior to the single bout of exercise, 
tests were conducted to estimate single- and two-legged aerobic performance. 
Three days before the bout of exercise subjects were asked to reduce physical 
activity. 7 randomly chosen untrained subjects were asked to consume the ACE 
inhibitor Lisinopril (10 mg daily; Zestril, AstraZeneca) in the morning, including on 
the day of the exercise test. Subjects reported to the laboratory in the fasted state. 
Blood pressure was measured in a calm place in seated position with a 
sphygmomanometer after the subject has been sitting for at least 15 minutes. 
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Subjects then performed a standardized one-leg exercise test to voluntary 
exhaustion. This intervention was chosen in order to maximize the metabolic 
stimulus for recruited muscle groups, without that central aspects pose a limitation 
that may interact with the systemic effects of ACE activity on blood pressure and 
perfusion (McPhee et al. 2009). Immediately before, 3 hours after exercise, biopsy 
samples were collected from the vastus lateralis (knee extensor) muscle from both 
the resting and exercised legs. In untrained subject not consuming Lisinopril a 
further 8 hours biopsy was collected. Biopsies were used for the characterization of 
Tenascin-C transcript expression using RT-PCR.  
Group 2 included 36 healthy, non-specifically trained, young, male subjects of 
Swiss descent. The subjects were asked to refrain from extra physical activity for 2–
4 weeks before the start of the study and endurance training program. Basic 
anthropometry and aerobic performance were assessed by a single bout of bicycle 
ergometer exercise two days before and after training, and muscle biopsies were 
collected from the vastus lateralis muscle. The biopsies were used for 
characterization of tissue composition using morphometric and molecular analysis. 
Molecular analysis included characterization of Tenascin-C protein expression and 
genotyping of the SNP rs2104772 within the Tenascin-C gene. 
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Ethics  
The study protocols were approved by the ethics board of Manchester 
Metropolitan University (group 1; Manchester, United Kingdom) and the ethics 
committee of the Canton of Berne (group 2; Berne, Switzerland). All investigations 
were performed in accordance with the ethical standards of the 1964 Declaration of 
Helsinki. Written informed consent was obtained from every participant. Previous 
publications report the anthropometry and exercise performance and the 
consequences of a single bout of exercise and of training on volume density of 
mitochondria and capillarity for group 2 (Luthi et al. 1986, Schmutz et al. 2010, 
Schmutz et al. 2006, Suter et al. 1995).  
 
Endurance test  
In both groups, aerobic performance was assessed with ergospirometry. Two 
weeks before the first bout of exercise, subjects were familiarized with the test 
equipment. Exercise tests were conducted using a bicycle ergometer (Ergoline 800S; 
Ergoline GmbH, Bitz, Germany). Expired air was analyzed with breath-by-breath 
measurements (Oxycon alpha; Jäger GmbH, Würzburg, Germany) and heart rate 
was monitored using an Accurex Plus chest belt (Polar Electro Finland, Kempele, 
Finland). Starting at 40 watts, the workload was increased by 30 watts every 2 min 
until the subjects could no longer maintain a cadence of over 60 rpm. Group 1 
underwent an additional test to determine aerobic performance of one-legged 
exercise. 
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Endurance training  
Subjects trained for 6 weeks, with five 30-minute sessions per week, 
maintaining 65% of their maximal aerobic performance. Training intensity was 
monitored and adjusted based on heart rate. The training workload was increased as 
necessary to maintain a constant training heart rate corresponding to 83 ± 1% of 
the individual’s maximal heart rate in the first training week, and to 90 ± 2% in the 
sixth training week. Before and after training, tissue was collected from the belly 
portion of the vastus lateralis muscle using a modified Bergstroem biopsy device 
with local anesthesia administered via subcutaneous injection of 1 mL 2% lidocaine, 
as previously described (Hoppeler et al. 1985).  
One-legged exercise  
Subjects completed a bout of one-legged exercise (using their dominant leg) 
on the stationary bicycle at a set cadence of 80 rpm under ergospirometry 
(Ergometrics Ergoline 800; Jaeger, Bitz, Germany). Saddle length was set to the 
same value used for two-legged exercise. The shoe of the dominant leg was 
attached to the pedal with duct tape, while the other leg rested on the frame in the 
middle of the ergometer or on a chair next to the bicycle. Subjects performed a 
warm-up at 15% of the calculated two-legged Pmax. Next, the subjects exercised 
for 25 minutes at 30% of the two-legged Pmax, after which the set intensity was 
ramped up in 10-Watt increments each minute until exhaustion. At the end of the 
exercise period, a 3-minute cool-down phase was allowed at 15% of the calculated 
two-legged Pmax. V̇O2, CO2, and ventilation were monitored with a MetaLyser® 3B 
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system operated with MetaSoft® software (Cortex Biophysik GmbH, Leipzig, 
Germany), and peak V̇O2 and maximal RER were determined. 
Biopsies were collected from the belly portion of the vastus lateralis muscle 
using a TSK Acecut 11G needle device (UK biopsy) under local anesthesia via 
subcutaneous injection of 1 mL 2% lidocaine. Before and immediately after the bout 
of exercise, 5 mL of blood was drawn from the cephalic vein into a K2E BD 
Vacutainer® tube sprayed with dry EDTA (Belliver Industrial Estate, Phymouth, UK). 
The tube was immediately placed on ice, and a 2-mL aliquot was rapidly processed 
to measure the angiotensin 2 concentration. 
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Figure 1. One-legged exercise protocol. Line graph depicting the characteristics of the one-legged exercise stimulus. Oxygen 
uptake (continuous line) and the work rate during the warm-up, constant load, and ramp phases (stippled line) are shown. A clear 
peak of intensity can be identified 
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Quantification of serum angiotensin 2 concentration   
A 2-mL aliquot of venous blood was pipetted into a 2-mL Eppendorf tube on 
ice, which contained an inhibitor cocktail to prevent angiotensin 2 degradation (0.44 
mM o-phenanthroline, 25 mM EDTA, 1 mM p-chloro-mercuribenzoic acid, and 0.12 
mM pepstatin A). The samples were centrifuged for 15 minutes at 3000 rpm at 4°C, 
and then the supernatant was transferred to a new 2-mL tube and stored at −80°C 
until further processing. Subsequently, the pre- and post-samples were thawed and 
enriched for the hydrophobic angiotensin 2 peptides using SPE reverse-phase C18 
cartridges (Cayman Chemical Company, Ann Arbor, MI, USA). The bound peptides 
were extracted with methanol into a glass tube, and dried down using a steam of 
nitrogen. The residue was dissolved in 250 µL EIA buffer, and two 100-µL aliquots 
were analyzed using the Ang II Enzyme Immunoassay kit (SPIBio Bertin Pharma, 
Montigny le Bretonneux, France) following the manufacturer’s instructions. After 10, 
30, and 60 minutes, the intensity of color development was recorded by 
spectrophotometry using an Automated Microplate Reader ELx800 (BIO-TEK® 
Instruments, Winooski, VT, USA). For each sample, the angiotensin 2 concentration 
was calculated using an angiotensin 2 standard curve. To establish the sensitivity 
and reproducibility of the assay, we initially ran test experiments with spiked 
angiotensin 2. 
 
Analysis of muscle tissue  
Muscle biopsies of group 2 were split in two portions. One portion was 
processed for electron microscopy to assess micro-anatomical characteristics of the 
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muscle cells and organelles based on morphometric analysis as previously described 
(Suter et al. 1995). The other portion was analyzed for Tenascin-C protein, SNP 
rs2104772 and ACE activity. Biopsies collected from group 1 were analyzed for 
muscle capillary density and capillary-to-fiber ratio and fiber cross-sectional area 
based on light microscopic measure of selected gene transcripts as previously 
described (Schmutz et al. 2010). 
 
Genotyping  
The targeted SNP rs2104772 was analyzed using high-resolution melt PCR 
(HRM-PCR). Genomic DNA was extracted from ~1-mm3 cryosections of the muscle 
biopsy using the DNeasy Blood and Tissue Kit (Qiagen Cat. No 69504) following the 
manufacturer’s protocol, essentially as previously described (45). DNA concentration 
and purity were measured using a NanoDrop USV-99 AGTGene (Labgene Scientific 
SA). Absorbance measurements at 260 and 280 nm indicated that the final DNA 
concentration ranged from 10 to 50 ng/μL and that the DNA was of high purity. DNA 
samples were diluted to a final concentration of 5 ng/µL and stored at −20°C until 
analysis. Genotyping was performed with HRM-PCR combined with sequencing. 
Available online tools (i.e., Primers-BLAST: 
http://www.ncbi.nlm.nih.gov/tools/primer-blast/; and Primer 3 output: 
http://primer3.ut.ee) were used to design oligonucleotide primers to target the 
Tenascin-C polymorphism (rsNCBI: rs2104772; SNP-44513-AT). The designed 
primers (5′-GATGAAGGGGTCTTCGACAA-3′ and 5′-TCGCCTTCCTTTGCTTATTC-3′) 
amplified a 168-bp fragment containing the SNP rs2104772.  
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The PCR reaction specificity was validated in experiments with negative and 
positive controls and by confirming the predicted PCR product size via agarose gel 
electrophoresis. This was followed by DNA band isolation and subsequent DNA 
sequencing by Microsynth (Balgach, Switzerland). The negative control was a non-
template control reaction (NTC) with DNAse-free water and positive controls 
comprised genotyped DNA samples, including samples for each genotypic variant of 
rs2104772 (i.e., A/T, A/A, and T/T). The positive controls also served as internal 
references to generate a melting profile for screening unknown samples.  
HRM-PCR reactions were run in duplicate. The reaction mix included 10 ng 
DNA template, 1× KAPA HRM FAST Master Mix (KAPA BIOSISTEMS, Labgene 
scientific SA, Châtel-St-Denis, Switzerland), 2.5 mmol MgCl2, 0.2 µmol of each 
primer, and water up to a final volume of 10 µL. Amplification and melt curve 
analysis was then performed using a EcoTM Thermal and Optical system (Illumina; 
Labgene Scientific SA, Châtel-St-Denis, Switzerland). The reaction conditions were as 
follows: 3 minutes enzyme activation at 95°C; followed by 35 amplification cycles of 
5 seconds denaturation at 95°C and 30 seconds annealing/extension at 60°C; and a 
final melting cycle of heating to 95°C, cooling to 55°C, and ending at 95°C. For each 
cycle, the fluorescent signal from the EvaGreen-dye contained in the 1× KAPA HRM 
FAST Master Mix was analyzed using EcoStudy software (Illumina, Labgene Scientific 
SA). This software automatically calculated and clustered the samples into three 
groups based on the melting profile, and the results were displayed as derivative 
normalized melting curves and peaks.  
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Transcript expression  
Total RNA was isolated from a 10-mm3 biopsy divided into 20-µm sections 
using an RNeasy Mini Kit (Qiagen, cat N° 74104) and Proteinase K (Qiagen, cat N° 
19131) as described by Schmutz-Hoppeler (Schmutz et al. 2010). The isolated RNA 
was stored overnight at −20°C. The RNA concentration and quality were determined 
using a NanoDrop USV-99 AGTGene (Labgene Scientific SA, Switzerland). 
From 600 ng RNA, cDNA was reverse transcribed using an OMNIscript Kit 
(Qiagen, cat N° 205110) that uses random hexamers, following the manufacturer’s 
protocol. RT-qPCR was performed for Tenascin-C, VEGF-A and the 28S rRNA gene 
for normalization. Into each well was added cDNA corresponding to an estimated 
input of 0.6 µg (0.06 µg for 28S), with a final reaction volume of 10 µL. Pooled 
primer pairs (200 nM each) and KAPASybr FAST Master MIX 2X (KAPA BIOSISTEMS, 
KK4600) were added and the reaction was performed using an EcoTM Thermal and 
Optical System (Illumina, Labgene Scientific SA, Switzerland). The following primers 
were obtained from Microsynth (Balgach, Switzerland): Tenascin-C (5′-
ACCTCTCTGGAATTGCTCCCA-3′, 5′-CATCTGAAACTAGAAGGTTGTC-3′); VEGF-A (5’-
CAT GGC AGA AGG AGGAGG GCA GAA TCA-3’, 5’-ATC TTC AAG CCA TCC TGT GTG 
CCC CTG-3’); 28S rRNA (5′-ATA TCC GCA GCA GGT CTC CAA-3′, 5′-GAG CCA ATC 
CTT ATC CCG AAG-3′). Each sample was amplified in duplicate using the following 
conditions: preheating at 95°C for 2 min; followed by 40 cycles of 95°C for 15 s and 
60°C for 1 min. Transcript amounts were determined with the ΔCT method, taking 
individual efficiency into account. The calculated values were standardized to the 
amounts of 28S.  
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Detection of Tenascin-C protein  
From the biopsy material, total protein homogenate was prepared and 
subjected to SDS-PAGE and immunoblotting for Tenascin-C essentially as previously 
described (Fluck et al. 2008). Briefly, 10 mm3 of muscle tissue was cross-sectioned 
to 25 µm using a cryostat and mixed with ice-cold RIPA buffer that included 10 mM 
Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% NP-40, 2% Triton X100, 2 mM 
EDTA, 2 mM EGTA, one PhosStop tablet, and one tablet of Complete-mini EDTA-Free 
reagent (Roche Diagnostics GmbH, Mannheim, Germany). This mixture was 
homogenized using a Polytron®PT 1200E hand-held homogenizer (Kinematica AG, 
Lucerne, Switzerland). The amount of protein in the total homogenate was 
determined using the BCA method (Pierce, Rockford IL, USA) against bovine serum 
albumin (BSA) as a standard. The total homogenate was adjusted to a concentration 
of 2 µg per µL using Laemmli buffer (Biorad Laboratories AG, Cressier, Switzerland) 
and 2% mercaptoethanol, and the mixture was heated at 95°C for 5 min.  
Next, 20 µg total protein was separated on hand-made 7.5% polyacrylamide 
gels in a Mini-Protean III electrophoretic system (BioRad Laboratories AG, Cressier, 
Switzerland). Samples of pre- and post-training pairs were loaded separately in 
adjacent lanes, with four sample pairs loaded per gel. Proteins were subsequently 
transferred onto nitrocellulose membrane (Protean, Amersham), the blotting 
efficiency was visualized by Ponceau S staining. Immunodetection was performed 
using the Tenascin-C antibody B28.13 (a gift from Prof. Matthias Chiquet) at a 1:50 
dilution, and secondary horseradish peroxidase-conjugated anti-rabbit IgG raised in 
102 
 
goat (MP Biomedicals, #55676). The bands corresponding to the tagged proteins 
were detected using chemoluminescence (Femto kit; Pierce, Fisher Scientific AG, 
Wohlen, Switzerland) and recorded using a Chemidoc system with Quantity One 
software (Bio-Rad, Life Science Research, Hercules, CA, USA). Band signal intensity 
was estimated using the “volume rectangular tool” and was corrected versus the 
background of a band of equal height and size (area) from an empty sample lane. 
Background-corrected data were normalized to actin, and then normalized to the 
mean values of the pre-training sample from the same gel. Therefore, the final 
values reflect the relative expression levels per total muscle protein.  
 
Measurement of ACE activity 
The analysis of ACE activity in muscle tissue before exercise was carried out using a 
fluorometric assay as modified from the published method of Sentandreu and Todra 
(2006) (Sentandreu et al. 2006). In brief, 10 mm3 of biopsy material from vastus 
lateralis muscle was cross-sectioned in a cryostat and homogenate was prepared in 
ice-cold 0.1M KH2PO4 buffer using a Polytron®PT 1200E hand-held homogenizer 
(Kinematica AG, Lucerne, Switzerland). Protein concentration was determined using 
the BCA method (Pierce, Rockford IL, USA) against BSA as a standard.  
in 100 µl 0.1M KH2PO4 buffer was 
assessed by adding 200 µl of solution containing 0.45 mM of substrate o-
aminobenzoylglycyl-p-nitro-L-phenylalanyl-L-proline (Abz-Gly-Phe(NO2)-Pro; Bachem 
cat. no. M-1100) and 1.125M NaCl in 150mM Tris-base buffer (pH 8.3). Reactions 
were run in duplicate for 4 hours at 37°C in the dark in a flat bottom OptiPlate 96 
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well microplate (Perkin Elmer, cat. No.6005290). Fluorescence was measured using 
a Multi-detection Microplate Reader (SynergyTM HT, BioTek Instruments) at 
respective excitation and emission wavelengths of 360nm and 460nm. The 
coefficient of variation of repeated measures was 9%. The specificity of ACE-
mediated substrate cleavage was monitored in control reactions where 1µM Lisinopril 
(Ratiopharm, Madrid-Spain) was added. This was compared to signal of control 
incubations with 7.5µg ml-1 of purified ACE enzyme (rabbit-lung, Sigma, cat. no. A-
6778) in the presence or absence of Lisinopril 1 µM. Under these conditions 96% 
and 75% of substrate conversion by the purified enzyme and total homogenate, 
respectively, was blocked with Lisinopril. The signal was calibrated versus the 
emission of o-amino-benzoylglycine (Abz-Gly; Bachem cat. no. E-2920) as titrated 
between concentrations of 1.5 and 20 µM. 
 
Immunohistological detection of Tenascin-C protein  
Cryosections were prepared from vastus lateralis muscle, and subjected to 
immunological staining for Tenascin-C using the MA3 antibody essentially as 
previously described (16). Nuclei were counterstained with hematoxylin. 
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Statistics  
 
All statistical analyses were performed using Statistica 10 (Statsoft, Tulsa, 
USA). Changes between the pre- and post-training findings were analyzed with a 
repeated ANOVA for the factor “genotype rs2104772” (A/A, A/T, or T/T) and the 
repeated factor “training” (yes or no). Fisher’s post-hoc test was chosen based on 
whether data were normally distributed. To compare training-induced changes 
between parameters, values were normalized to the pre-training values prior to the 
ANOVA. Compliance with Hardy-Weinberg equilibrium was assessed using an online 
calculator, i.e., http://www.had2know.com/academics/hardy-weinberg-equilibrium-
calculator-2-alleles.html. Post- vs. pre-exercise changes in 
Tenascinhttp://www.had2know.com/academics/hardy-weinberg-equilibrium-calculator-2-
alleles.html. Post- vs. pre-exercise changes in -C expression were assessed using a 
paired T-test. Relationships were calculated based on Spearmans rank correlations 
and called significant at p<0.05. 
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RESULTS 
 
Effect of training state on Tenascin-C transcript expression after single endurance 
exercise  
Table 1 presents the anthropometric data for the subjects of group 1. We 
assessed Tenascin-C expression in vastus lateralis muscle after one-legged exercise 
in the first 8 hours after exercise because a robust response was reported for this 
time frame (Busso et al. 2013, Egan et al. 2013, Schmutz et al. 2010). The 
characteristics of the exercise stimulus are shown in Fig. 1. Tenascin-C transcript 
levels were increased eight hours after endurance exercise in trained, but unaltered 
in untrained (p=0.92), subjects (Fig. 2A). Tenascin-C transcript levels were neither 
altered three hours after endurance exercise in the untrained subjects (Fig. 2B). 
 
Effect of ACE inhibition on Tenascin-C/VEGF transcript expression after exercise  
Intake of the ACE inhibitor Lisinopril produced an increase in Tenascin-C 
transcript levels in vastus lateralis of untrained subjects three hours after exercise 
(Fig. 2B). Similarly, VEGF-A transcript levels were specifically increased 3 hours after 
exercise under Lisinopril intake (Fig. 2C). Level alterations in Tenascin-C and VEGF 
transcript with exercise demonstrated an interaction effect with Lisinopril treatment 
(Tenascin-C: P=0.09, VEGF: P=0.04). 
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Table 1: Performance characteristics of subjects of group 1 (mean ± SE). * denotes 
P<0.05 vs. untrained subjects without Lisinopril. 
 
 untrained subjects untrained subjects  trained subjects 
 without lisinopril with lisinopril  
parameter (n=7) (n=7) (n=7) 
 
Age [years] 23.1 ± 1.5 33.7 ± 3.2 27.1 ± 2.6 
Weight [kg]  75.1 ± 4.8 76.3 ± 5.7 80.9 ± 4.1 
Height [cm]  178.2 ± 3.0 175.3 ± 4.2 182.9 ± 2.1 
VO2 max 2-leg 47.6 ± 1.5 49.3 ± 2.5 60.2 ± 2.6 * 
[ml O2.min-1.kg-1] 
Pmax 2-leg [W]  270.0 ± 13.5 295 ± 15.1 370.0 ± 15.6* 
VO2 max 1-leg 40.6 ± 1.8 44.6 ± 4.7 46.5 ± 1.8 * 
[mL O2.min-1.kg-1] 
Pmax 1-leg [W]  169.3 ± 9.9 174 ± 10.9 233.6 ± 9.7 * 
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2a) 
 
 
 
 
 
 
2b)  
 
 
 
 
 
 
Figure 2. Tenascin-C /VEGF/VEGF-A transcript levels after one-legged exercise. (a, 
top) Bar graph visualizing the mean + SE of Tenascin-C transcript levels in trained 
and untrained subjects 8 hours after one-legged exercise (n = 7). Tenascin-C (b, 
bottom) and VEGF-A (c, page 108) transcript levels 3 hours post-exercise in 
untrained subjects with or without consumption of the ACE inhibitor Lisinopril (n = 7 
each group). *P < 0.05 vs. pre-exercise values (paired T-test). 
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2c) 
 
 
 
 
 
 
 
 
 
Figure 2c. For description of figure 2a-c see page 107  
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Effect of exercise and ACE inhibition on ACE activity and angiotensin 2 levels  
Mean serum concentration of angiotensin 2 increased 1.6-fold after the bout 
of one-leg endurance exercise in untrained, but not trained subjects (p=0.04 vs 
0.34; table 2). Mean serum angiotensin 2 concentrations also increased 1.4-fold 
after endurance exercise in untrained subjects that consumed Lisinopril. This 
increase did not differ to subjects that did not consume Lisinopril (P = 0.682). ACE 
activity in vastus lateralis muscle before exercise was higher in untrained subjects 
that consumed Lisinopril compared to untrained and trained subjects that did not 
consume Lisinopril (table 1). Blood pressure was not affected by Lisinopril 
consumption (table 2). Fold changes in serum angiotensin 2 concentrations after 
exercise were negatively correlated to muscle ACE activity at baseline (rho=-0.75). 
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Table 2: Angiotensin related parameters of group 1 (mean ± SE). * denotes P<0.05 
vs. untrained subjects without Lisinopril. $ denotes P<0.05 vs. values before 
exercise. 
 
 untrained subjects untrained subjects  trained subjects 
 without lisinopril with lisinopril  
 
 
Blood pressure at rest 
Systolic [mm Hg] 117.3 ± 2.6 128.8 ± 5.6 120.5 ± 2.5 
Diastolic [mm Hg] 69.7 ± 2.9 71.6 ± 4.0 73.2 ± 1.7 
Blood pressure at rest after 3 days Lisinopril 
Systolic [mm Hg]  129.4 ± 4.3  
Diastolic [mm Hg]  66.2 ± 4.0  
ACE activity [pmol min-1 mg-1 protein] 
before exercise 36.5 ± 5.9 67.4 ± 13.5 * 37.0 ± 6.4 
Angiotensin 2 [pg mL-1] 
before exercise   18.4 ± 3.3 17.4 ± 7.1  17.6 ± 7.9 
after exercise 29.9 ± 7.9 $ 25.0 ± 10.2 $ 40.8 ± 18.2 
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Effects of endurance training  
In group 2, we assessed the effect of endurance training on Tenascin-C 
protein expression. Table 3 reports the pre-training biometric data of the studied 
subjects. Endurance training on the bicycle ergometer improved V̇O2max (+9%) and 
local components of aerobic fitness in the vastus lateralis muscle, including the 
capillary-to-fiber ratio (+13%), capillary density (+10%), and mitochondrial density 
(+24%; table 3).  
Association of Tenascin-C expression with training  
Tenascin-C was present in the vastus lateralis muscle in both 250-kDa and 
200-kDa isoforms (Fig. 3). Endurance training increased the concentrations of both 
the large (77 ± 29% increase) and small (128 ± 54% increase) isoforms. Tenascin-C 
staining was associated with capillary structures and blood vessels in the interstitium 
(Fig. 3C-E). 
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Table 3: Biometric characteristics of subjects of group 2 (mean ± SE) 
parameters before Training 
  (n=36) 
Age [years] 32.9  ± 1.6 
Weight [kg]  77.4 ± 2.3 
Height [cm]  177.6 ± 1.2 
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3a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3a-e. Tenascin-C protein isoforms in vastus lateralis with endurance 
training. (a, above) Immunoblot showing the small (180 kDa) and large (230 kDa) 
Tenascin-C isoforms in one subject before and after endurance training. The position 
of the actin band (loading control) on the Ponceau S-stained membrane before 
immunoblotting is indicated. (b, page 114) Bar graph of mean + SE of the fold 
changes in Tenascin-C expression. *P < 0.05 vs. pre. ANOVA with Fisher’s post-hoc 
test (n = 17). (c, page, 117; d, page 116) Tenascin-C staining (orange staining) in 
the vastus lateralis muscle of one subject before (c, page 115) and after (d, page 
116) endurance training and in another subject before training (page, 119). Nuclei 
are stained in blue. Arrows and arrowheads point to Tenascin-C staining in capillary 
structures and blood vessels. Bar = 100 µm. 
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Figure 3b. description for figure 3 see page 113 
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3c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3b. description for figure 3 see page 113 
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3d) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3d. description for figure 3 see page 113 
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3e) 
 
 
 
 
 
Figure 3e. description for figure 3 see page 113 
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SNP rs2104772 within the Tenascin-C gene affects training-induced gains in muscle 
capillary-to-fiber ratio 
With regard to several muscle parameters, we assessed the influence of the 
Tenascin-C SNP rs2104772, which is characterized by a thymidine-to-adenosine 
exchange at nucleotide position 44,513. Fig. 4 presents an example of the 
genotyping reaction. Statistical analysis revealed that we could not reject the 
assumption that the study population was in a Hardy-Weinberg equilibrium (P = 
0.0854, n=36). 
The baseline data showed that the small Tenascin-C isoform tended to be 
present in 28% lower amounts among individuals with the T/T variant compared to 
those with A/T (p=0.045). Endurance training improved aerobic function and 
produced adjustments of associated structures in vastus lateralis muscle, i.e. 
capillaries, mitochondria and myofibrils (table 4). Three of these parameters 
demonstrated an interaction effect between endurance training x polymorphism 
rs140772 (P < 0.01, table 3). Figure 5 resolves the values for the three respective 
genotypes of polymorphism rs2140772. This concerned the volume density of 
central mitochondria per fiber, the volume density of total mitochondria per fiber and 
capillary-to-fiber ratio: Capillary-to-fiber ratio was increased in subjects with an ‘A-
allele’ (i.e., the A/T and A/A genotypes of rs2104772), while this structural variable 
was reduced in those with the T/T genotype (−14%; fig. 5). Equally, the volume 
density of total mitochondria per fiber was increased in the A/T and A/A genotype 
after training and this distinguished to an unaltered value for this parameter in the 
homozygous T/T genotypes. The volume density of central mitochondria was 30% 
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increased only in association with the heterozygous genotype A/T but was not 
altered in those with the homozygous A/A and T/T genotypes. The fold changes in 
Tenascin-C protein with endurance training were not significantly associated with 
SNP rs2104772. 
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4a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4a-f. Analysis of SNP rs2104772 by HRM. (a, above; b, page 121; c, page 
122)  Detected melting curves for the different genotypes, i.e., the homozygote A/A 
(red) and homozygote T/T (blue) relative to the heterozygote A/T (green). Every 
sample was analyzed in duplicate. (a, above) Raw data of the pre-melt, melt, and 
post-melt regions. (b, page 121) Normalized data derived from the raw data plots. 
(c, page 122) Curves derived from the normalized data with the A/A genotype set as 
a (horizontal) baseline. NTC, negative control (yellow). (d, page 123; e, page 124; f, 
page 125) Sequence analysis of the three identified genotypes in chromatograms 
presenting the forward sequence. Arrows link the single-nucleotide polymorphism 
(SNP) position 44,513. 'W' denotes heterozygosis for the SNP where a double-peak 
is present at position 44,513 for both sequenced alleles (nucleotides A and T 
simultaneously).  
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Figure 4b. for a description of figure 4 see page 120 
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Figure 4c. for a description of figure 4 see page 120 
 
  
123 
 
4d) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4d. for a description of figure 4 see page 120 
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4e) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4e. for a description of figure 4 see page 120 
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4f) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4f for a description of figure 4 see page 120 
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Figure 5. Genotype effect (rs140772) on the response of muscle variables to 
endurance training. Bar graph indicates the mean + SE of the fold changes in the 
three parameters of muscle energy supply that showed a genotype effect in regard 
to the response to endurance training. Fold changes are shown separately for the 
three genotypes of SNP rs140772 in the Tenascin-C gene—i.e., A/A (n = 8), A/T (n 
= 23), and T/T (n = 5). Abbreviations: Vv(mt,f), volume density of total 
mitochondria; Vv(mc,f), volume density of central mitochondria; NN(c,f), capillary-
to-fiber ratio. *P < 0.05 for the indicated comparison, ANOVA with Fisher’s post-hoc 
test. 
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DISCUSSION 
 
Repeated blood flow increases are a major regulator of normal physiological 
angiogenesis in skeletal muscle (Egginton et al. 2001, Prior et al. 2004). The 
consequent increase in capillary density and capillary-to-fiber ratio conspires with 
exercise-induced vasodilatation to improve substrate supply to contracting skeletal 
muscle (Egginton et al. 2001, Mortensen et al. 2012, Prior et al. 2004). Flow-induced 
gains in muscle capillary density depend on the vasoconstrictor angiotensin 2 
(Greene 1998). We previously demonstrated that genetic inhibition of angiotensin 2 
production (through the presence of the I-allele within the ACE gene) exerts a 
negative influence on capillary density in vastus lateralis muscles of untrained 
subjects (Vaughan et al. 2013). In the current study, we assessed the associations of 
these effects with exercise-induced serum levels of angiotensin 2 and the expression 
of the pro-angiogenic extracellular matrix protein Tenascin-C (5), which has been 
suggested to induced by angiotensin 2 in smooth muscle cells during vascular 
remodeling in hypertension (Mackie et al. 1992). We hypothesized that endurance 
training-induced gains in capillarity are modulated by ACE activity and by the SNP 
rs2104772 within the Tenascin-C gene, which was predicted to affect adhesive 
function and the molecular interactions of this protein (Danser et al. 2007, Rigat et al. 
1990) (Fig. 6). 
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Figure 6. Interactions between exercise-induced responses in serum angiotensin 
and Tenascin-C and with regard to angiogenesis. Lines with arrows of a hyphen at 
the end, respectively, indicate promotion or inhibition of the connected process. A 
curved line indicates a qualitative effect. Grey lines represent the interactions 
identified in this investigation. 
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Obviously, certain limitations apply when drawing mechanistic conclusions 
from a sport-medical intervention in humans which involves genetic analyses. The 
polymorphism within the Tenascin-C gene was studied in subjects with different 
genetic backgrounds, although they shared the same ethnicity. Additionally, the 
number of subjects included in the study population was low compared to that in 
many genetic studies. However, due to the invasive nature of the study (requiring an 
otherwise unnecessary muscle biopsy), we were ethically bound to use as few 
subjects as possible. In order to avoid that a potential regulation of transcript 
expression would have been missed, the sample points for our study were set to 
times in the window between 3-12 hours after exercise when the major expression 
response in vastus lateralis muscle during recovery from two-legged bicycle 
ergometer exercise occurs (Busso et al. 2013, Egan et al. 2013, Schmutz et al. 
2010). Despite these considerations we were unable to assess the effect of single 
leg exercise and Lisinopril 3 hours after the exercise in trained subjects. 
Furthermore, the present comparison of the effects of two different exercise types 
(i.e., one-legged and two-legged exercise) poses a potential limitation for the 
interpretation. The one-legged type of exercise was selected to increase the 
metabolic strain on the exercised and tested muscle— maximizing the stimulus for 
recruited muscle group, while reducing the effects of central restraints on exercise 
performance (McPhee et al. 2009). While supporting a role of ACE for the expression 
of the pro-angiogenic factors Tenascin-C and VEGF-A in untrained muscle after 
exercise, the underlying mechanism, and its involvement in training-induced 
angiogenesis awaits further exploration. In this regard, we identify that studying the 
influence of polymorphism rs2104772 on training-induced adjustments in muscle 
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composition provides a valid approach to probe the implication of Tenascin-C in 
capillary remodeling.  
The identified effects of rs2104772 on gains in capillary density and capillary-
to-fiber ratio with endurance training (Fig. 5), support the notion that Tenascin-C is 
actively involved in the processes that instruct exercise-induced capillary growth. By 
contrast, other structural parameters related to myofibrils were not affected (table 
4). In fact, increases in the capillary-to-fiber ratio alone reportedly reflect effective 
capillary remodeling, as volume density alterations often mirror volumetric changes 
in muscle fiber cross-section (Egginton et al. 1998). This suggests that the function 
of Tenascin-C is associated with the activity-induced structural rearrangement of 
capillaries with respect to muscle fibers. 
Our present molecular characterization focused on the observed modulation 
of endurance training-induced muscle capillarity by SNP rs2104772, which exists 
within the coding region of the Tenascin-C gene. The T-to-A exchange at nucleotide 
position 44,513 leads to the substitution of isoleucine instead of leucine at amino 
acid position 1677 in the C-terminal FNIII domain of TNC (Matsuda et al. 2005). 
Based on structural modelling this domain was predicted to recognize the 13th 
fibronectin type III domain of fibronectin, and therefore this SNP interferes with 
fibrinogenesis and wound healing (Chiquet et al. 2003). The structural model 
predicts that the presence of isoleucine rather than leucine causes beta-sheet 
instability and may negatively affect Tenascin-C molecular elasticity (Matsuda et al. 
2005, Saunders et al. 2013), thus reducing the capacity of Tenascin-C to dissolve 
cell–matrix contacts. While experimental proof for this molecular interaction is 
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missing, the in here identified effects of rs2107772 on muscle capillarity and the 
association of rs2107772 with the Achilles tendon rupture and asthma provide a 
further indication for the functional relevance of the resultant amino acid exchange 
for Tenascin’s interactions within the extracellular matrix (Matsuda et al. 2005, 
Saunders et al. 2013). Hence, the observed larger increase in capillary density 
associated with the A/A and A/T genotypes as opposed to the T/T genotypes are 
intriguing. This ambivalence suggests that a reduced elasticity and altered functional 
interaction of Tenascin-C with its extracellular partners are potential parameters to 
explore the biophysical foundation that underlies the superior gains in muscle 
capillarity in A/A and A/T genotypes of SNP rs2107772.  
The latter observation is also of interest because subjects heterozygous for 
SNP rs2104772 showed the largest increase in central mitochondria after endurance 
training (Fig. 5). This suggests the possibility that this observation may result from 
an equilibrium of two opposing processes: the interaction of an optimal condition for 
mitochondrial biogenesis with endurance exercise in the A/A variant, offset by 
respiratory problems associated with the A/A genotype (Matsuda et al. 2005, 
Saunders et al. 2013). We cannot presently directly address this interpretative 
hypothesis, as differences in oxygenation or ventilation were not assessed in the 
current study.  
Increased Tenascin-C expression promotes neovascularization, and its 
enhanced expression by vascular smooth muscle cells may mediate angiotensin II-
induced changes in vascular structure during hypertension (Ballard et al. 2006, 
Mackie et al. 1992). Both endothelial and smooth muscle cells are potential sites of 
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Tenascin-C expression and action (Ballard et al. 2006, Intengan et al. 2000, Vollmer 
et al. 1990). The presently observed Tenascin-C expression in the studied muscle 
group (Fig. 3C–E) is consistent with an expression in the capillary endothel. Smooth 
muscle cells are mainly found in the arterioles of skeletal muscle, which integrate 
exercise-modulated control of muscle perfusion through inhibition of angiotensin-
mediated smooth muscle cell constriction/contraction via repeated contractions of 
the adjacent muscle fibers (Clifford et al. 2004, Wunsch et al. 2000). In this regard, 
it was puzzling that the expression responses of the small and large Tenascin-C 
isoforms to endurance training were not significantly affected by the rs2104772 
polymorphism (Fig. 3A/B). This suggests that the observed effect of rs2104772 may 
reflect a role of Tenascin-C in the stabilization of newly formed capillaries, rather 
than in promoting capillary growth. The present findings corroborate the view that 
Tenascin-C may have an important influence on the adaptations in mitochondria and 
capillaries that are typically connected with endurance training (Hoppeler et al. 
1985). 
An intriguing finding of our investigation was that ACE activity in vastus 
lateralis muscle was nearly two-fold higher in subjects which consumed Lisinopril 
and that this did not attenuate the rise in serum angiotensin 2 concentration post 
exercise (table 2). This observation relates to reports that ACE inhibitor intake 
(captopril) does not blunt the increase in angiotensin 2 post exercise (Aldigier et al. 
1993), and that Lisinopril increases the renal and cardiac expression of ACE and 
ACE2, the latter of which counteracts ACE action (Jessup et al. 2006). As well we 
identified that blood pressure was not significantly affected by Lisinopril intake (table 
2) although this is commonly observed with early treatment. Collectively, the 
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findings suggest that compensatory reactions of the angiotensin system were set in 
motion in skeletal muscle in consequence of the 3 days of Lisinopril consumption 
(reviewed in Avanzini et al. 2002). Thereby the negative correlation between fold 
changes in serum angiotensin 2 concentrations after exercise and muscle ACE 
activity highlights a possibly complex relationship of local and systemic renin-
angiotensin system which may reflects the role of shear stress for endothelial ACE 
expression as well (Barauna et al. 2011). 
An interesting aspect in this regard was the detection of an increased 
expression of the Tenascin-C transcript at three hours after one-legged exercise 
under Lisinopril consumption in untrained subjects but when the Tenascin-C 
transcript of untreated subjects was, unlike in trained subjects, not affected until 
eight hours post exercise (Fig. 2). This relationship possibly reflects differences in 
vasomotor reactivity and downstream muscle perfusion between trained and 
untrained subjects. With the onset of exercise, perfusion of skeletal muscle rapidly 
increases due to the inhibited contraction of smooth muscle cells in pre-capillary 
sphincters (Clifford et al. 2004). This vasodilatation is greater in trained subjects due 
to their elevated capillary density (Lithell et al. 1981) and exaggerated functional 
sympatholysis (Mortensen et al. 2012). The consequent hyperemia is a main 
contributor to the increased shear stress to capillary walls that, together with 
abluminal forms of stress, triggers angiogenesis in contracting skeletal muscle 
(Egginton et al. 2001). Our present findings bind Tenascin-C into this mechanism 
and suggest that exercise-induced Tenascin-C expression is established with 
repeated exercise. The observed interaction effects between exercise x Lisinopril 
treatment on Tenascin-C and VEGF transcript levels, do together with the higher ACE 
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activity levels in untrained subjects under Lisinopril treatment and post-exercise 
increases in serum angiotensin 2 concentrations indicate that expression of these 
pro-angiogenic transcripts in muscle depends on ACE activity.  This observation is in 
line with the observation that an angiotensin II-related mechanism regulates VEGF 
during angiogenesis with chronic electrical stimulation of rat skeletal muscle (Amaral 
et al. 2001). 
It is worth noting that we examined Tenascin-C-associated angiogenesis in 
the health-associated situation of exercise. This observation differs from that in 
studies assessing the role of Tenascin-C in vascular growth in pathological blood 
vessel remodeling as occurs in chronic angiotensin-mediated hypertension, 
implantation of a balloon catheter, or tumor growth (Egginton et al. 2001, Mackie et 
al. 1992, Majesky 1994, Mustafa et al. 2012). Such situations are characterized by 
chronic changes in cell composition and chronic inflammation, which deteriorate 
tissue function. Conversely, the increased capillarity with physical training is a part of 
quantitative changes in muscle composition that improve the energy supply to 
contracting muscle (Wibom et al. 1992, Zumstein et al. 1983). 
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Conclusion  
 
Here we provide evidence for a role of Tenascin-C in exercise-induced 
capillary growth and mitochondrial biogenesis in the skeletal muscle of men. Further 
studies are needed to explore the precise cellular elements of the biological pathway 
underlying the observed plasticity of energy supply lines with repeated endurance 
exercise, which we find to include ACE-related Tenascin-C expression and to be 
modulated by SNP rs2104772 within the Tenascin-C gene. 
 
ACKNOWLEDGEMENTS 
The authors acknowledge the essential contributions of Franziska Graber and 
Helga Claasen to the morphometric analysis and the medical consent of Dr. med. 
Jurek Krupinsky. 
 
GRANTS 
Financial support was received from the Move-Age consortium (Sv,G.), a 
grant from Manchester Metropolitan University grant (D.V., M.F.), and the 
RESORTHO Foundation (M.F.). 
  
136 
 
AUTHOR CONTRIBUTIONS 
Author contributions: P.V., Sv.G., Ad.H, H.H., and M.F. conception and design 
of research; P.V., Sv.G., S.W., and M.F. performed experiments; P.V., Sv.G., S.W., 
and M.F. analyzed data; P.V., H.H., and M.F. interpreted results of experiments; 
Ad.H. and M.F. funding; P.V. and M.F. prepared figures; P.V. and M.F. drafted the 
manuscript; P.V., Sv.G., and M.F. edited and revised the manuscript 
Experiments performed by Sv.G. (ACE inhibition group): Taking informed consent, 
height, weight, blood pressure, glucose, cycling ergometer tests, blood processing, 
AngII assessment, Tenascin-C and VEGF transcript levels measurements 
 
  
137 
 
REFERENCES 
Aldigier JC, Huang H, Dalmay F, Lartigue M, Baussant T, Chassain AP, Leroux-Robert 
C, and Galen FX. Angiotensin-converting enzyme inhibition does not suppress plasma 
angiotensin II increase during exercise in humans. J Cardiovasc Pharmacol 21: 289-
295, 1993. 
Amaral SL, Linderman JR, Morse MM, and Greene AS. Angiogenesis induced by 
electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation 8: 57-
67, 2001. 
Avanzini F, Ferrario G, Santoro L, Peci P, Giani P, Santoro E, Franzosi MG, and 
Tognoni G. Risks and benefits of early treatment of acute myocardial infarction with 
an angiotensin-converting enzyme inhibitor in patients with a history of arterial 
hypertension: analysis of the GISSI-3 database. Am Heart J 144: 1018-1025, 2002. 
Badr I, Brown MD, Egginton S, Hudlicka O, Milkiewicz M, and Verhaeg J. Differences 
in local environment determine the site of physiological angiogenesis in rat skeletal 
muscle. Exp Physiol 88: 565-568, 2003. 
Ballard VL, Sharma A, Duignan I, Holm JM, Chin A, Choi R, Hajjar KA, Wong SC, and 
Edelberg JM. Vascular tenascin-C regulates cardiac endothelial phenotype and 
neovascularization. Faseb J 20: 717-719, 2006. 
Barauna VG, Campos LC, Miyakawa AA, and Krieger JE. ACE as a mechanosensor to 
shear stress influences the control of its own regulation via phosphorylation of 
cytoplasmic Ser(1270). PLoS One 6: e22803, 2011. 
138 
 
Brothers R, Haslund M, DW. W, Raven P, and Sander M. Exercise-induced inhibition 
of angiotensinII vasoconstriction in human thigh muscle. J Physiol 577: 11, 2006. 
Busso T and Fluck M. A mixed-effects model of the dynamic response of muscle 
gene transcript expression to endurance exercise. Eur J Appl Physiol 113: 1279-
1290, 2013. 
Chiquet-Ehrismann R and Chiquet M. Tenascins: regulation and putative functions 
during pathological stress. J Pathol 200: 488-499, 2003. 
Clapp C, Thebault S, Jeziorski MC, and Martinez De La Escalera G. Peptide hormone 
regulation of angiogenesis. Physiol Rev 89: 1177-1215, 2009. 
Clifford PS and Hellsten Y. Vasodilatory mechanisms in contracting skeletal muscle. J 
Appl Physiol (1985) 97: 393-403, 2004. 
Danser AH, Batenburg WW, van den Meiracker AH, and Danilov SM. ACE 
phenotyping as a first step toward personalized medicine for ACE inhibitors. Why 
does ACE genotyping not predict the therapeutic efficacy of ACE inhibition? 
Pharmacol Ther 113: 607-618, 2007. 
Egan B and Zierath J. Exercise Metabolism and the Molecular Regulation of Skeletal 
Muscle Adaptation. Cell Metabolism 17: 23, 2013. 
Egginton S, Hudlicka O, Brown MD, Walter H, Weiss JB, and Bate A. Capillary growth 
in relation to blood flow and performance in overloaded rat skeletal muscle. J Appl 
Physiol (1985) 85: 2025-2032, 1998. 
139 
 
Egginton S, Zhou AL, Brown MD, and Hudlicka O. Unorthodox angiogenesis in 
skeletal muscle. Cardiovasc Res 49: 634-646, 2001. 
Fluck M, Chiquet M, Schmutz S, Mayet-Sornay MH, and Desplanches D. Reloading of 
atrophied rat soleus muscle induces tenascin-C expression around damaged muscle 
fibers. Am J Physiol Regul Integr Comp Physiol 284: R792-801, 2003. 
Fluck M, Mund SI, Schittny JC, Klossner S, Durieux AC, and Giraud MN. Mechano-
regulated tenascin-C orchestrates muscle repair. Proc Natl Acad Sci U S A 105: 
13662-13667, 2008. 
Greene AS. Life and death in the microcirculation: a role for angiotensin II. 
Microcirculation 5: 101-107, 1998. 
Hahn AW, Kern F, Jonas U, John M, Buhler FR, and Resink TJ. Functional aspects of 
vascular tenascin-C expression. J Vasc Res 32: 162-174, 1995. 
Hoppeler H, Howald H, Conley K, Lindstedt SL, Claassen H, Vock P, and Weibel ER. 
Endurance training in humans: aerobic capacity and structure of skeletal muscle. J 
Appl Physiol (1985) 59: 320-327, 1985. 
Hudlicka O, Brown M, and Egginton S. Angiogenesis in skeletal and cardiac muscle. 
Physiol Rev 72: 369-417, 1992. 
Husain K, Ansari RA, and Ferder L. Alcohol-induced hypertension: Mechanism and 
prevention. World J Cardiol 6: 245-252, 2014. 
Intengan HD and Schiffrin EL. Role of Adhesion Molecules and Extracellular Matrix 
Determinants. Hypertension 36: 7, 2000. 
140 
 
Jarvinen TA, Jozsa L, Kannus P, Jarvinen TL, Hurme T, Kvist M, Pelto-Huikko M, 
Kalimo H, and Jarvinen M. Mechanical loading regulates the expression of tenascin-C 
in the myotendinous junction and tendon but does not induce de novo synthesis in 
the skeletal muscle. J Cell Sci 2003 116: 857-866,. 
Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Chappell MC, and 
Ferrario CM. Effect of angiotensin II blockade on a new congenic model of 
hypertension derived from transgenic Ren-2 rats. Am J Physiol Heart Circ Physiol 
2006 291: H2166-2172. 
Korthuis R. Skeletal Muscle Circulation: Morgan & Claypool Life Sciences, 2011. 
Lithell H, Lindgarde F, Hellsing K, Lundqvist G, Nygaard E, Vessby B, and Saltin B. 
Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting 
serum insulin concentration and glucose tolerance in 48-year-old men. Diabetes 
1981 30: 19-25. 
Luthi JM, Howald H, Claassen H, Rosler K, Vock P, and Hoppeler H. Structural 
changes in skeletal muscle tissue with heavy-resistance exercise. Int J Sports Med 
1986 7: 123-127. 
Mackie EJ, Scott-Burden T, Hahn AW, Kern F, Bernhardt J, Regenass S, Weller A, 
and Buhler FR. Expression of tenascin by vascular smooth muscle cells. Alterations in 
hypertensive rats and stimulation by angiotensin II. Am J Pathol 1992 141: 377-388. 
Majesky MW. Neointima formation after acute vascular injury. Role of 
counteradhesive extracellular matrix proteins. Tex Heart Inst J 1994 21: 78-85. 
141 
 
Matsuda A, Hirota T, Akahoshi M, Shimizu M, Tamari M, Miyatake A, Takahashi A, 
Nakashima K, Takahashi N, Obara K, Yuyama N, Doi S, Kamogawa Y, Enomoto T, 
Ohshima K, Tsunoda T, Miyatake S, Fujita K, Kusakabe M, Izuhara K, Nakamura Y, 
Hopkin J, and Shirakawa T. Coding SNP in tenascin-C Fn-III-D domain associates 
with adult asthma. Hum Mol Genet 2005 14: 2779-2786. 
McPhee JS, Williams AG, Stewart C, Baar K, Schindler JP, Aldred S, Maffulli N, 
Sargeant AJ, and Jones DA. The training stimulus experienced by the leg muscles 
during cycling in humans. Exp Physiol 2009 94: 684-694. 
Mortensen SP, Nyberg M, Gliemann L, Thaning P, Saltin B, and Hellsten Y. Exercise 
training modulates functional sympatholysis and alpha-adrenergic vasoconstrictor 
responsiveness in hypertensive and normotensive individuals. J Physiol 2014 592: 
3063-3073. 
Mortensen SP, Nyberg M, Winding K, and Saltin B. Lifelong physical activity 
preserves functional sympatholysis and purinergic signalling in the ageing human 
leg. J Physiol 2012 590: 6227-6236. 
Mustafa DA, Dekker LJ, Stingl C, Kremer A, Stoop M, Sillevis Smitt PA, Kros JM, and 
Luider TM. A proteome comparison between physiological angiogenesis and 
angiogenesis in glioblastoma. Mol Cell Proteomics 2012 11: M111 008466. 
Prior BM, Yang HT, and Terjung RL. What makes vessels grow with exercise 
training? J Appl Physiol 2004  97: 1119-1128. 
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, and Soubrier F. An 
insertion/deletion polymorphism in the angiotensin I-converting enzyme gene 
142 
 
accounting for half the variance of serum enzyme levels. J Clin Invest 1990 86: 
1343-1346. 
Saunders CJ, van der Merwe L, Posthumus M, Cook J, Handley CJ, Collins M, and 
September AV. Investigation of variants within the COL27A1 and TNC genes and 
Achilles tendinopathy in two populations. J Orthop Res 2013 31: 632-637. 
Schmutz S, Dapp C, Wittwer M, Durieux AC, Mueller M, Weinstein F, Vogt M, 
Hoppeler H, and Fluck M. A hypoxia complement differentiates the muscle response 
to endurance exercise. Exp Physiol 2010 95: 723-735. 
Schmutz S, Dapp C, Wittwer M, Vogt M, Hoppeler H, and Fluck M. Endurance 
training modulates the muscular transcriptome response to acute exercise. Pflugers 
Arch 2006 451: 678-687. 
Sentandreu MA and Toldrá F. A fluorescence-based protocol for quantifying 
angiotensin-converting enzyme activity. Nat Protoc 2006 1: 5. 
Sharifi B, DW. L, CJ. P, JS. F, and JA. F. Angiotensin II regulates tenascin gene 
expression in vascular smooth muscle cells. J Biol Chem 26: 1992 6. 
Staessen J, Fagard R, Hespel P, Lijnen P, Vanhees L, and Amery A. Plasma renin 
system during exercise in normal men. J Appl Physiol 1987 63: 7. 
Suter E, Hoppeler H, Claassen H, Billeter R, Aebi U, Horber F, Jaeger P, and Marti B. 
Ultrastructural modification of human skeletal muscle tissue with 6-month moderate-
intensity exercise training. Int J Sports Med 16: 1995 160-166. 
143 
 
Vaughan D, Huber-Abel FA, Graber F, Hoppeler H, and Fluck M. The angiotensin 
converting enzyme insertion/deletion polymorphism alters the response of muscle 
energy supply lines to exercise. Eur J Appl Physiol 2013 113: 1719-1729. 
Vollmer G, Siegal GP, Chiquet-Ehrismann R, Lightner VA, Arnholdt H, and Knuppen 
R. Tenascin expression in the human endometrium and in endometrial 
adenocarcinomas. Lab Invest 1990 62: 6. 
Wibom R, Hultman E, Johansson M, Matherei K, Constantin-Teodosiu D, and Schantz 
PG. Adaptation of mitochondrial ATP production in human skeletal muscle to 
endurance training and detraining. J Appl Physiol 1992 73: 2004-2010. 
Wunsch SA, Muller-Delp J, and Delp MD. Time course of vasodilatory responses in 
skeletal muscle arterioles: role in hyperemia at onset of exercise. Am J Physiol 2000 
279: H1715-H1723. 
Zumstein A, Mathieu O, Howald H, and Hoppeler H. Morphometric analysis of the 
capillary supply in skeletal muscles of trained and untrained subjects--its limitations 
in muscle biopsies. Pflugers Arch 1983 397: 277-283. 
 
  
144 
 
Chapter 5 
Adjustments of Muscle Capillarity But not Mitochondrial Protein 
with Skiing in the Elderly 
 
Sander van Ginkel1,2, Myriam Amami1, Flemming Dela3, David Niederseer4, Marco 
Narici1,5, Josef Niebauer4, Peter Scheiber6, Erich Müller6, Martin Flück1,7 
 
1 The Institute for Biomedical Research into Human Movement and Health 
(IRM), Manchester Metropolitan University, Manchester, United Kingdom 
2 MOVE Research Institute Amsterdam, Faculty of Human Movement Sciences, VU 
University Amsterdam, Amsterdam, the Netherlands 
3 Xlab, Department of Biomedical Sciences, Center for Healthy Aging, Faculty of 
Health Sciences, University of Copenhagen, Copenhagen, Denmark 
4 University Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus 
Medical University, Salzburg, Austria 
5 University of Nottingham, School of Graduate Entry Medicine and Health, Derby 
Royal Hospital, Derby, United Kingdom 
6 Department of Sport Science and Kinesiology, University of Salzburg, Salzburg, 
Austria 
7 Department of Orthopaedics, University of Zurich, Zurich, University Hospital 
Balgrist, Switzerland 
145 
 
Abstract 
 
Downhill skiing in the elderly increases maximal oxygen uptake (VO2max) and 
carbohydrate handling, and produces muscle hypertrophy. We hypothesized that 
adjustments of the cellular components of aerobic glucose combustion in knee 
extensor muscle, and cardiovascular adjustments, would increase in proportion to 
VO2max. 
Nineteen healthy elderly subjects (age 67.5 ± 2.9 years) who completed 28.5 days 
of guided downhill skiing over 3-months were assessed for anthropometric variables, 
cardiovascular parameters (heart rate, haematocrit), VO2max and compared to 
controls (n=20). Biopsies of vastus lateralis muscle were analysed for capillary 
density and expression of respiratory chain markers (NDUFA9, SDHA, UQCRC1, 
ATP5A1) and the glucose transporter GLUT4. Statistical significance was assessed 
with a repeated ANOVA and Fisher’s post hoc test at a p-value of 5%. 
VO2max increased selectively with ski training (+7±2%). Capillary density 
(+11±5%) and capillary-to-fibre ratio (12 ± 5%), but not the concentration of 
metabolic proteins, in vastus lateralis was increased after skiing. Cardiovascular 
parameters did not change. Fold changes in VO2max and capillary-to-fibre ratio were 
correlated, and were under genetic control by polymorphisms of the regulator of 
vascular tone, ACE. The observations indicate that increased VO2max after 
recreational downhill ski training is associated with improved capillarity in a mainly 
recruited muscle group. 
 
 
146 
 
Introduction 
 
Downhill skiing is a popular outdoor activity. The muscular adjustments to ski 
training are poorly understood despite the considerable interest in this leisure time 
activity (Berg et al. 1995; Muller et al. 2011). It has recently been pointed out that 3 
months of recreational downhill skiing positively affects physical fitness and 
psychological well-being in elderly subjects (Dela et al. 2011; Finkenzeller et al. 
2011). Increased leg strength due to an enlarged cross section of slow type muscle 
fibres and improved whole body aerobic capacity, were identified as two important 
contributors to the effects of skiing on fitness (Dela, Niederseer 2011). 
Aerobic metabolism appears to account for a larger portion of the energy demand 
during low intensity, downhill exercise on the slope (Scheiber et al. 2009) and gains 
in importance with increased training and skill level (Tesch et al. 1978). Due to the 
considerable mechanical requirements on extensor muscles, a large portion of 
muscle becomes activated during slow contractions (Berg & Eiken 1999); elevating 
glucose metabolism (Scheiber et al., Krautgasser et al. 2009; Tesch et al. 1978  , 
Larsson et al. 1978; Tesch 1995). 
Three elements of the pathway which supplies environmental oxygen to working 
skeletal muscle, i.e. oxygen transport system, muscle capillarity and mitochondria, 
are known to set aerobic capacity (di Prampero 1985). As shown previously with 
other modalities of training, the repeated increase in energy expenditure with 
contractile work induces a compensatory response to cover the increased metabolic 
demand of contracting muscle (Baldwin 1996). Thereby it appears that the degree of 
plasticity at the local, i.e. muscle level, exceeds the one of central (i.e. cardiac) 
147 
 
mechanisms and oxygen transport capacity (Hoppeler et al. 1985). Regarding 
skeletal muscle, an increased capacity of at least two biochemical processes 
contribute to the improved aerobic conversion of blood-borne glucose in contracting 
skeletal muscle: Firstly, this may include elevated capillarity together with improved 
capacity for contraction- induced glucose uptake via the facilitative glucose 
transporter 4 (GLUT4; Dela et al. 1993). Secondly, prolonged exercise may produce 
an increase in mitochondrial volume density (Fluck & Hoppeler 2003), which we 
have shown previously is matched by maximal oxygen uptake (Kayar et al. 1994; 
Oosterhof et al. 2011). 
We therefore hypothesized that Alpine skiing will increase the capacity for aerobic 
combustion of glucose in knee extensor muscles being recruited during skiing via an 
increase in capillary density and the concentration of mitochondrial protein in 
proportion with an improvement in VO2max. This was tested by assessing changes in 
aerobic capacity in a group of healthy active elderly that attended a guided skiing 
intervention of 3-months duration and compared to a control group that refrained 
from skiing over the winter season. Capillary density and the content of enhancers 
for glucose uptake (i.e. GLUT4) and markers of mitochondrial respiratory complex I, 
II, III and V in the major knee extensor, m. vastus lateralis (Berg, Eiken 1995), were 
assessed in the skiing group before and after ski training. As adjustments to 
endurance exercise and elevated altitude have been shown to be affected by the 
insertion / deletion polymorphism (i.e. ACE I/D) in the gene for angiotensin 
converting enzyme (Vaughan et al. 2013; Woods et al. 2000) we assessed whether 
the response in elements of the pathway that sets aerobic capacity would be 
modified by the ACE I/D genotype. 
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Methods 
 
Experimental design-A full description of the recruitment procedure, the design of 
the study and the participant’s characteristics is given in the paper of Müller et al. 
(2011). In short, a group of 27 healthy subjects on a beginners or intermediate level 
of alpine skiing (13 females (age: 67.2 ± 0.8 years; mean ± SE) and 14 males (age: 
67.7 ± 0.8 years) started a 12-week skiing intervention. In parallel, a control group, 
consisting of 10 female subjects (age: 66.3 ±1.2 years) and 10 male subjects (age: 
68.2 ± 1.6 years) was recruited and asked to live their normal life but they were not 
allowed to ski during the study. Baseline measurements, including the collection of a 
muscle biopsy in the skiing group, were carried out in an entry test before the 
intervention and the same measurements were repeated after the 12 weeks of 
skiing. Due to various reasons 5 subjects (i.e. 3 females, 2 males) dropped out 
during the intervention (Niederseer et al. 2011). The Ethics Committee of the 
University of Salzburg, Austria, approved the study. Informed consent was obtained 
from all participants before testing. The study thus meets the ethical standards of 
the journal. 
Skiing protocol- 19 subjects completed the 12-week skiing intervention which 
consisted of a total of 28.5 ± 0.6 days of on average 3.5 hours of guided skiing in 
the Salzburg Ski Amadé resort (altitude 728-2700 m above sea level). Subjects were 
divided into four homogeneous performance groups according to their skiing skills 
on the first day. On average they descended 4885 meter during nine runs on the 
slope (6.6 minutes per run) per day. 
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Entry and exit test- Weighing and measuring of the subjects was conducted using 
high precision tools (Seca 709 and Seca 224, Seca, Hamburg, Germany) and fat 
mass was assessed as previously published using a calliper in 4 standardized points 
as described (Niederseer et al. 2011). Erythrocyte content was measured in a 
venous blood sample that was drawn from the cubital vein of the subjects (Narici et 
al. 2011; Niederseer et al. 2011). Muscle thickness before and after training was 
determined using a digital ultra-sonographer (MyLab25, Esaote, Genoa, Italy) with 
the subjects lying supine on a gurney. Scans were acquired at 50% of muscle 
length, mid-belly, in the mid-sagittal plane using a 7–10MHz linear-array probe. Care 
was taken to assure the scanning of the same anatomical location pre and post 
training by positioning the ultrasound probe in the mid-sagittal plane, orthogonal to 
the mediolateral axis, versus reference points that were collected by marking the 
probe position on acetate paper using moles and small angiomas. Muscle thickness 
was defined as the distance between the deep and the superficial aponeuroses. 
Muscle thickness was estimated using the public domain NIH software ‘‘ImageJ’’ 
(version 1.42q, National Institute of Health, USA, http://rsb.info.nih.gov/ij) from the 
average of three measurements along the aponeurosis. Aerobic exercise capacity 
was also assessed before and after ski training in an incremental performance test 
on a stationary cycle ergometer as described elsewhere (Muller et al. 2011). Maximal 
aerobic performance (Pmax) and maximal oxygen uptake (VO2max) were 
determined using ergospirometry. Due to technical inaccuracy of data sampling, 
VO2max values at baseline were excluded in three subjects from further analysis. 
Heart rate (HR) was registered by continuous ECG and blood pressure was 
measured every two minutes during ergometry. During ski training HR was 
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monitored by Suunto watches and heart rate belts (t6, Suunto, Helsinki, Finland). A 
biopsy was collected from vastus lateralis muscle of the left leg prior to and 5-7 days 
after ski training with a Weil-Blakely conchotome (Gebrueder Zepf Surgical 
Instruments, Dürbheim, Germany), snap frozen and stored at -80°C. 
Muscle histology - Frozen biopsy samples were mounted with Tissue-Tek® OCT TM 
on cork and 15-µm cross-sections were prepared using a cryostat (Leica CM 1800) 
by adjusting the cutting plane in perpendicular direction to the major axis of the 
muscle fibres. Sections from pairs of pre/post samples were mounted on Superfrost 
slides (Menzel, Germany), dried at room temperature and stored in sealed tubes at -
80°C. Slides were stained using a lectin antibody as described by Ahmed et al. 
(1997). In brief, slides were thawed, fixed with acetone for 15 min, blocked with 0.1 
% BSA in HEPES for 60 min, incubated with a peroxide solution for 30 min and 
incubated with the lectin antibody (Ulex Europeus 50 μg/ml in 1 % BSA in HEPES). 
Between every step, a 5 min wash with HEPES was conducted. For the colour 
reaction, the Vectastain ABC and DAB kit (Vector Laboratories, Peterborough, UK) 
were used. Slides were finally embedded in glycerol gelatine (Sigma) and covered 
with cover slips. 
Quality of the staining was inspected and signal was recorded at 20x magnification 
against the scale of a 1-mm-graticle with an Axiocam MRc camera that was mounted 
on a microscope (Zeiss Axioskop 2 mot plus). The different images of one section 
were combined in one final image using Microsoft Paint software. Dark areas, double 
cut areas, and inappropriate areas were removed. Images were processed with 
Image J software (version 1.43; http://rsbweb.nih.gov/ij/download.html). Capillaries 
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were identified using a red filter with a sample window between 0-120, and counted 
with a pixel size of 8-150. Only pixel areas demonstrating a circularity factor 
between 0.3-1.0 were selected. The scale was adjusted and the area of the analysed 
section covered by muscle fibres was measured using a brightness filter with a 
standardized between 0-208. The number of capillaries per square millimetre was 
defined as capillary density and was averaged per subject. On average 302 ± 49 and 
391 ± 60 capillaries were counted per muscle cross-section pre and post the skiing 
intervention, respectively. The cross sectional area of slow and fast type muscle 
fibres was previously assessed (Narici, Flueck 2011). In brief, frozen biopsies of m. 
vastus lateralis were sectioned at a separate occasion at twelve-micrometer 
thickness under a cutting plane that was adjusted in perpendicular direction to the 
major axis of the muscle fibres. The criteria for accepting a specific cutting angle 
were that the majority of the fibre profiles showed a ratio between the smallest and 
the largest diameter of 0.66 and above and that no further reduction of this ratio 
was apparent despite tilting the biopsy before sectioning. Cryosections were 
subjected to staining for type II myosin heavy chain and the signal was recorded 
digitally with an Axiocam MRc camera at a 10-fold magnification (Zeiss Axioskop 2 
mot plus, Carl Zeiss Ltd, Welwyn Garden City, UK). We had previously shown that 
the majority of fibres were pure fibres. Therefore the cross-sectional area of stained 
(fast type) and unstained (slow type) fibres was determined against the scale by 
manually recording the fibre periphery of each assessed fibre within the ARDOM 
software (Degens et al. 2002). These numbers were used to calculate the 
percentage and MCSA of slow- and fast-type muscle fibres. On average, 56 slow- 
and 49 fast-type muscle fibres were counted per muscle cross-section. 
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Muscle biochemistry – Cryosections equivalent to a tissue volume of 10mm3 were 
collected during sectioning and pooled frozen in a 2 ml Eppendorf tube. Total 
homogenate was prepared in cold RIPA buffer (50 mM Tris-HCl (pH 7.5), 150 mM 
NaCl, 1 mM EDTA, 1% NP-40, 0.25% sodium deoxycholate at 90% + fresh (1 mM 
NaF, 1 mM Na3VO4, 1 μg/ml leupeptin, 2 μg/ml pepstatin, 1 μg/ml aprotinin, 1 mM 
PMSF) with an Ultraturrax mixer on ice. Protein content was estimated against 
bovine serum albumine with the bicochinic acid kit (Pierce). SDS-extracts were 
prepared at 1 microgram/ microliter in SDS-Page loading buffer (50 mM Tris.HCL, pH 
6.8, 10% glycerol, 2% SDS, 2%-mercaptoethanol, 0.1% bromphenol blue) by 
mixing and heating for 5 min at 95°C followed by a spin 1 min at 5000 g 25°C. The 
denatured proteins were then separated on a 7.5 or 10% SDS-PAGE on a Biorad 
mini electrophoresis system, western blotted on a nitrocellulose membrane 
subjected to immunodetection with commercial antibodies in a 0.05% Tween-Tris 
buffer system (TTBS) essentially as described (Flueck et al. 2011). The membrane 
was stained with Ponceau S before immunodetection to control for equal loading and 
protein transfer. 
For mitochondrial proteins a 1:1000 dilution in TTBS/2.5% milk,/1% BSA of first 
anti-OxPhos Complex Kit from Invitrogen (catalog # 457999) composed of 
monoclonal antibodies against markers of complex I (NDUFA9), complex II (SDHA), 
complex III (UQCRC1), and complex V (ATP5A1) and 1:10000 dilution in TTBS/2.5% 
milk/1% BSA of secondary of horse radish peroxidase-conjugated goat anti-mouse 
antibody (ICN Biomedicals GMBH, Germany) was used. GLUT4 was detected with a 
1:1000 dilution of polyclonal rabbit anti GLUT4 antiserum (MiIlipore, #07-1404) as 
two to three bands between 40 and 50 kDa as previously reported (Kristiansen & 
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Richter 2002) and 1: 5000 dilution of horse radish peroxidase-conjugated secondary 
anti-rabbit antibody from goat (ICN Biomedicals GMBH, Germany) in TTBS/2.5% 
milk/1% BSA , respectively. Signal detection was carried out with enhanced 
chemoluminescence (Femto kit, Pierce) and quantified with a Chemidoc system 
running under Quantity One software (Bio-Rad, Life Science Research, Hercules, CA, 
USA). The signal intensity of the respective band was estimated with the ‘volume 
rectangular tool’ and corrected for background of a band of equal height and size 
(area) in an empty sample lane. A paired loading design was employed to load equal 
amounts (20 microgram) of total homogenate against pre-stained marker Amersham 
RPN 756V for size determination. Background-corrected signals of proteins were 
normalised to actin and then normalized to the mean values of the respective 
samples before training to reveal relative protein concentrations. 
Genotyping- The ACE genotype was assessed essentially as described in (Vaughan, 
Huber-Abel 2013) but with the modification that the reaction was run on 
homogenates of muscle cross sections in RIPA buffer. 
Statistics – Statistical tests were calculated using Statistica 10.0 (Statsoft Inc, Tulsa, 
USA). Kolmogorow-Smirnow-Lilliefors-Test demonstrated that the assumption of a 
normal distribution could not be rejected at a p-value of 0.10. Post vs. pre skiing 
were assessed with a one-way repeated ANOVA with a two-tailed post-hoc test of 
Fisher. Linear relationships were assessed based on Pearson correlations at a p-
value < 0.05. 
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Results 
 
Downhill ski training-induced changes in body composition and exercise capacity: 
Tables 1 and 2 show the anthropometry of subjects, as well as exercise capacity and 
their changes with 3 months of downhill ski training. Body fat percentage was 
reduced by 8±2% but body weight was not affected (p=0.065; table 1). The 
thickness of vastus lateralis muscle was increased by 7±2% after skiing and this was 
matched by hypertrophy of slow type muscle fibres (table 1). Mass-specific VO2max 
increased by 7±2% after the training program. Mass-specific VO2max, body weight, 
fat content and the thickness of vastus lateralis muscle were not affected in the 
control subjects (tables 1 and 2). 
Cardiovascular parameters with skiing: Heart rate at rest and after exertion 
demonstrated a trend for a reduction after ski training (p=0.06, table 3). 
Haematocrit was not significantly affected by ski training. 
Adjustments of capillary processes with downhill ski training: Figure 1 shows a 
representative detection of capillary density in vastus lateralis muscle. Capillary 
density (+11 ± 5%) and capillary-to-fibre ratio (12 ± 5%) were increased after 3 
months of skiing (Fig. 1). 
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Table 1: Anthropometry of subjects in function of skiing. Values represent 
mean + SEM. prior and post ski training. N=22, repeated ANOVA with post-hoc test 
of Fisher. 
 
 pre post p-value 
body weight [kg] 79.4 ± 2.9 78.1  ± 2.9 0.065 
BMI [kg/m3] 27.1  ± 0.7 26.6 ± 0.7 0.062 
body fat [%] 27.5  ± 2.4 26.8 ± 1.8 <0.001 
vastus lateralis muscle    
thickness [mm] 189  ± 6 202 ± 7 0.001 
CSA slow fibres [μm2] 5643  ± 412 6837 ± 568 0.040 
CSA fast fibres [μm2] 4701  ± 490 5342 ± 454 0.070 
Slow fibre area [%] 58 ± 5% 63  ± 4% 0.320 
Capillary density [mm-2] 402 ± 35 431 ± 35 0.105 
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Table 2: Exercise capacity in function of skiing. Values represent mean + SEM 
prior and post ski training. N=22, repeated ANOVA with post-hoc test of Fisher. 
 
 pre post  p-value 
Pmax [watts] 174.8 ± 45.1 176.7 ± 47.3 0.446 
Watts/ kg 2.2  ± 0.5 2.3  ± 0.5 0.102 
VO2-max [ml/kg/min] 28.7  ± 5.0 30.7  ± 5.4 0.001 
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Table 3: Cardiovascular parameters in function of skiing. Values represent 
mean + SEM of heart rate (HR) in beats per minute (bpm) and blood pressure 
during exercise and haematocrit as estimated in entry and exit tests. N=22, 
repeated ANOVA with post-hoc test of Fisher. 
 
heart rate pre post p-value 
HR rest (bpm) 71.6 ± 13.4 68.2 ± 9.3 0.065 
HR max exertion (bpm) 153.3 ± 11.4 152.8 ± 13.2 0.062 
HR 5 min recovery (bpm) 113.5 ± 15.2 111.0 ± 16.0 0.424 
systolic blood pressure [mmHg] 
rest 125.2 ± 12.8 123.0 ± 13.3  
max exertion  207.6 ± 26.4 212.4 ± 23.0 0.150 
5 min recovery (bpm) 160.5 ± 32.9 166.4 ± 32.4 0.461 
diastolic blood pressure [mmHg] 
rest 79.5 ± 11.3 77.9 ± 9.6  
max exertion  88.8 ± 12.3 89.5 ± 13.3 0.839 
5 min recovery (bpm) 72.6 ± 13.7 74.8 ± 16.5 0.635 
Haematocrit 43.5 ± 2.6 42.6 ± 2.8 0.111 
 
158 
 
 
 
 
 
 
 
Table 4: Concentration changes of metabolic processes with ski training. 
Mean ± SE of relative concentrations of selected metabolic factors in m. vastus 
lateralis. N=19, repeated ANOVA with post-hoc test of Fisher. 
 pre   post   p-value 
GLUT4 50-kDa 1.0 ± 0.2 1.3 ± 0.4 0.247 
GLUT4 40-kDa 1.0 ± 0.2 1.1 ± 0.3 0.394 
NDUFA9 1.0 ± 0.1 1.2 ± 0.1 0.139 
SDHA 1.0 ± 0.1 1.1 ± 0.1 0.349 
UQCRC1 1.0 ± 0.1 1.2 ± 0.1 0.101 
ATP5A1 1.0 ± 0.1 1.2 ± 0.1 0.105 
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Table 5: ACE I/D polymorphism affect the response to ski training. Mean 
values of fold changes with skiing between the three genotypes resulting from the 
ACE I/D polymorphism and the corresponding p-value for the genotype-affected 
parameters (ANOVA). 
 
fold change ACE-II ACE-ID ACE-DD p-value 
VO2-max [ml O2/min/kg] 1.01  1.06 1.13 0.042 
Capillary length [mm] 1.09  1.36 1.85 0.049 
Slow fibre area [%] 1.03  1.03 1.07 0.005 
Heart rate at rest [bpm] 0.88  0.96 1.15 0.005 
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1a)                                                            1b)  
 
 
 
 
 
 
 
1c) 
 
 
 
 
 
 
 
 
 
 
Figure 1a-d. Representative example of muscle capillarity. (a, top left; b top right) 
Example of detected capillaries in cross-sections of knee extensor muscle in a 
subject before (a, top left) and after (b, top right) ski training. Respective examples 
of stained capillaries are indicated with an arrow. Bar, 100 mm. (c, bottom; d, page 
161) Bar graphs of mean ± SE and lines for individual changes in capillary density 
(c, bottom) and capillary-to-fiber ratio (d, page 161) before and after the 3 months 
of downhill ski training. n = 19. *P < 0.05 vs pre (repeated analysis of variance with 
post-hoc test of Fisher). 
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1d) 
 
 
 
 
 
 
 
 
 
 
 
Figure1d: for discription of figure 1 see page 160 
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Figure 2: GLUT4 protein and respiratory chain constituent expression in human 
skeletal muscle with ski training. (a, b) Representative immunoblot of the detected 
GLUT4 immunoreactive protein at 40 and 50 kDa (a) and markers of four 
mitochondrial respiratory complexes I (NDUFA9), II (SDHA), III (UQCRC1), and V 
(ATP5A1) in vastus lateralis muscle in two subjects pre and post 3 months of ski 
training. (b) The respective bands and the weight of molecular markers are 
indicated. (c) Loading control of the Ponceau S stained membrane show skeletal 
alpha actin. 
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Figure 3: Correspondence between capillarity and maximal oxygen uptake (VO2-
max). Line graph showing the correlation between fold changes in capillary-to-fiber 
ratio in vastus lateralis muscle and VO2-max with 3 months of ski training.
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Glucose transport with skiing: Three GLUT-4 protein bands, residing as a doublet 
near 40-kDa and a single band at 50-kDa (Hoshino et al. 2013; Kristiansen & Richter 
2002), respectively were detected in vastus lateralis muscle (Fig. 2). Neither GLUT4 
isoform was altered in relative concentration after ski training (table 4). 
Unaffected expression of mitochondrial proteins with downhill skiing: Figure 1B 
shows representative immunoblots of the markers of the four mitochondrial 
respiratory complexes I (NDUFA9), II (SDHA), III (UQCRC1) and V (ATP5A1) in two 
subjects before and after the ski training. Concentrations of the mitochondrial 
markers were not significantly affected by ski training (table 4). 
Correlations between local and system variables: There was considerable variability 
in the response of mitochondrial protein and capillarity to the skiing program. The 
fold-changes in capillary-to-fibre-ratio in vastus lateralis muscle correlated with the 
fold-changes in mass-specific VO2max after ski training (r=0.59, p=0.02; Fig. 3). No 
correlations were observed between the fold-changes in mass-specific VO2max and 
those of capillary density and the concentration of mitochondrial proteins after 
skiing. Before skiing, linear relationships for mass-specific VO2max and the 
concentration of mitochondrial proteins were evident, i.e. SDHA (r=0.56), ATP5A1 
(r=0.53). Variability in the response of VO2max, heart rate at rest, and slow fibre 
area was related to an effect of the ACE I/D polymorphism (table 5). 
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Discussion 
 
Downhill skiing is known to elevate glycogen metabolization during slow aerobic and 
forceful eccentric muscle actions downhill on the slope (Scheiber, Krautgasser 2009; 
Tesch, Larsson 1978; Tesch 1995) and can improve aerobic fitness in the elderly 
when performed repeatedly (Muller, Gimpl 2011). Maximal oxygen uptake during 
endurance exercise, as a measure of aerobic fitness, is set by the connected 
elements of the intra-organ path involved oxygen transport from the lungs to muscle 
mitochondria (di Prampero 1985).  Thereby the larger portion (i.e. 3/4th) is allocated 
to cardiac output and oxygen binding to erythrocytes in blood with the remaining 
fraction being about equally partitioned between capillary cross section and 
mitochondria of working muscles.  Here we show that the effect of ski training on 
mass-specific VO2max is related to increases in capillary-to-fibre-ratio and capillary 
density but not mitochondrial protein concentration (compare Fig. 1 with table 4) in 
the major extensor muscle, m. vastus lateralis. 
Increases mass-specific VO2max after endurance training have been shown to be 
reflected by a locally exaggerated increase in mitochondria and capillary volume 
density (Hoppeler, Howald 1985). In line with the results in the former paper we 
identify a correlation between fold changes in mass-specific VO2max and the 
changes in capillary-to-fibre-ratio with ski training (Fig. 3). The identified trends for a 
decrease in heart rate, both at rest and during exercise, further indicate that central 
adaptations occur with the repeated downhill skiing (table 3). These observations 
suggest that the effects of improved capillarity in peripheral muscle conspire with 
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central changes to explain gains in VO2max with ski training of the elderly subjects 
of our study. 
Downhill skiing involves in addition to shortening and isometric forms of 
contraction, also a considerable degree of lengthening type (i.e. eccentric) 
contractions (Berg & Eiken 1999). In this regard it is of interest to compare the in 
here identified adaptations in capillarity and thickness of knee extensor muscle to 
training protocols, which involve alike skiing involve eccentric type contractions and 
aerobic exercise (Scheiber et al. 2009). For instance, it has been pointed out that 
eccentric type of endurance exercise on a modified cycle ergometer produces 47% 
and 52% increases in capillary-to-fibre ratio and muscle cross sectional area, 
respectively, after 8-weeks of training while leaving mitochondrial density unchanged 
(LaStayo et al. 2000). These adaptations distinguish to the concomitant increase in 
mitochondrial volume density (+40%) and capillary-to-fibre ratio (+40%) with 6-
weeks of the normal, ‘concentric type’, endurance training at 65% aerobic power on 
a cycle ergometer (Hoppeler et al. 1985). We have recently shown that adaptations 
in mitochondria with the latter endurance training protocol are reflected by increases 
of the concentration of mitochondrial proteins (NDUFA9, SDHA, COX4I1, UCP-3) in 
m. vastus lateralis by 60%-300% (Desplanches et al. 2013). While there is an 
appreciated influence of exercise intensity for training-induced alterations in 
mitochondrial enzymes in leg muscles (Schantz et al. 1983); the former observations 
emphasise that eccentric, as opposed to concentric type of endurance exercise, 
produce few adaptations in mitochondria in the recruited vastus lateralis muscle 
(Steiner et al. 2004). In contrast, the increased capillary-to-fibre ratio and capillary 
density, despite the expected dilution of capillaries in the larger vastii; highlight the 
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net increase in capillary supply in knee extensor muscle after ski training. Possibly 
this is explained by the role of mechanical factors as main stimulus for the growth of 
capillaries (Egginton 2011) as mechanical factors also are increasingly important with 
the eccentric type contractions during downhill turns on the slope (Berg & Eiken 
1999). 
An intriguing aspect of our study was that variability in the response of 
VO2max and heart rate at rest was related to the I/D polymorphism in the gene for 
angiotensin converting enzyme, ACE (table 5). We have recently demonstrated that 
the ACE I/D polymorphism affects the change in mass-specific VO2max and muscle 
capillarity of young subjects to endurance training on stationary cycle ergometers 
(Vaughan, Huber-Abel 2013). In that study subjects carrying the ACE I-allele were 
found to demonstrate larger increases in aerobic capacity than non-carriers of the I-
allele which carry the D-allele only. On the other hand, in the study described here, 
subjects with the D-allele demonstrated larger improvements in VO2max and 
capillary length in m. vastus lateralis after the moderate endurance stimulus. The 
present findings indicate a different influence of the ACE I/D polymorphism on the 
effects of concentric (i.e. cycle ergometer) versus eccentric (i.e. skiing) type of 
endurance exercise on aerobic capacity. Based on our data we hypothesize that 
different adjustments in heart rate, and possibly muscle perfusion, but the latter of 
which did not resolve at the level of statistical significance, contribute to the larger 
improvement in VO2max in homozygous carriers of the ACE D-allele. 
In contrast to our assumption, mitochondrial protein concentration was not 
increased in vastus lateralis muscle after the skiing program. These observations 
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indicate that adaptations of muscle energy supply lines with recreational skiing differ 
from the effects of recreational type of endurance training (Fluck & Hoppeler ; Suter 
et al. 1995). Our finding parallels the specific increase in capillarity (capillary-to-fibre 
ratio) with eccentric type, as opposed to concentric type, of endurance exercise 
(LaStayo, Pierotti 2000); suggesting that the observed adjustments in capillarity with 
skiing are driven by mechanical rather than metabolic factors. 
 
Limitations: In our study a number of co-variables of oxygen transport were not 
assessed (i.e. stroke volume) and the levels of molecules assessed in our wet assay 
were expressed respective to relative signal intensities (per total protein or muscle 
cross section) and not respective to absolute SI units. Also, only one factor was 
assessed that is involved in glucose metabolism in skeletal muscle, which we 
hypothesised to be improved based on the increase in glucose metabolism with 
downhill skiing and the effects of endurance type training on the concentration of 
GLUT4, being involved in the import of blood-borne glucose (Desplanches et al. 
2014; Scheiber et al. 2009; Tesch et al. 1978; Tesch 1995). However. GLUT4 is not 
a primary bottleneck in the regulation of glycolytic flux (Suarez et al. 2005) and 
glucose uptake and disposal was not measured. Therefore possible other modalities 
of GLUT4-related glucose handling cannot be excluded. Finally, we did not assess 
muscle parameters at the cellular and molecular level in the control group, which did 
not demonstrate a change in VO2max compared to the skiing group (table 2). This is 
explained by ethical considerations related to the (minimally) invasive of the biopsy 
sampling technique. Although we cannot formally exclude a contribution of the 
repeated exposure to moderate altitude (i.e. 728-2700 m above sea level) to the 
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increased capillarity in m. vastus lateralis after ski training we do not identify 
correlations between vertical distance covered during the skiing intervention with 
VO2max (r=-0.14, p=0.57), capillary density (r=-0.03, p=0.89), and capillary-to-fibre 
ratio (r=0.10, p=0.71). 
 
Conclusion 
 Recreational downhill skiing in the generally healthy elderly produces an increase in 
capillarity rather than increases in respiratory chain constituents in a main muscle 
group operating with downhill action on the slope. The underlying mechanisms 
remain to be explored but appear to involve eccentric type contractions and genetic 
effects of the angiotensin converting enzyme. 
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Chapter 6 
Summarizing discussion 
 
The aim of this research was to expose the pathway by which ACE and AngII are 
implicated in exercise-induced capillary growth of human muscle. In the introduction 
we hypothesize that the blunting of AngII production with concomitant exercise 
reduces improvements in metabolic fitness by removing an important stimulus for 
capillary growth in exercised muscle.  
AngII, ACE genotype and exercise 
In chapter 2 we described our investigation on the effect of exercise intensity and 
duration on serum AngII concentration. We observed that highest increases in 
indices of metabolic strain were observed after a maximal incremental exercise test, 
with a two-fold increase in serum AngII concentration after a very high intense 3-
minutes exercise test. The relative change in AngII in this stucy  compares well to  
the increase found in the study of Fagar et al. (1985). No significant increases in 
AngII were found after the 12-minutes test and maximal test with also no significant 
differences in AngII levels between the different time points after exercise (Fig. 2, 
page 46).  
We did find that the increase in AngII after exercise is dependent on the ACE 
I/D gene polymorphism. After the maximal incremental exercise test subjects with 
the ACE-ID/DD genotype showed a decrease in serum AngII concentration after the 
maximal test while serum AngII concentration was not affected in subjects with the 
ACE-II genotype (Fig. 3; page 47) Thus, the ACE I/D genotype explains part of the 
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variation in serum AngII levels between subjects. This indicates that the rise in 
AngII post exercise seems to be exercise intensity and ACE genotype dependent. 
It was further observed that subjects with the ACE-II genotype had a 
significant higher capillary perfusion in the finger after exercise compared to the 
ACE-ID/DD genotype. The observed trend for a lower capillary perfusion in the ACE-
ID/DD genotype post exercise indicates that this body compartment is less perfused 
due to AngII-dependent vasoconstriction during exercise. We conclude that there 
seems to be a relationship between AngII levels and ACE genotype and between 
ACE genotype and blood flow. 
 
Effects of ACE inhibition during exercise 
We investigated the impact of ACE inhibition to expose the role of AngII in 
angiogenic gene expression in exercised muscle by assessing the effect of ACE 
inhibition by oral medication (chapter 3). The AngII values were 1.6 times higher 
after exercise in the ACE inhibition group and were not significantly increased in the 
control group. This increase in AngII of both groups is comparable with the increase 
found in the the study of Fagard (1985). In our study we further identified that ACE 
inhibitor intake increased production of pro-angiogenic factors associated with the 
capillaries in the interstitium, i.e. VEGF and Tenascin-C (Milkiewicz, 2001; Flück, 
2000) after exercise and prevented the increase in oxygen dependent transcripts 
which are thought to mainly originate from muscle fibres (COX4I2, HIF-1α).  
Influence of ACE on Tenascin C expression during exercise 
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We investigated whether Tenascin C expression in exercised muscle is 
controlled by ACE activity (chapter 4). We found an effect of ACE inhibition by the 
anti-hypertensive drug lisinopril on the response of Tenascin-C after exercise and 
identified that Tenascin-C transcript expression was only increased in an endurance 
control group and not in untrained control subjects. This indicates that elevated 
Tenascin-C expression post exercise relies on the inhibition of angiotensin modulated 
vasoconstriction. We provided with this study evidence for a role of the angiotensin-
Tenascin-C axes during exercise-induced capillary growth and mitochondrial 
biogenesis in the muscle. 
ACE genotype and exercise training 
In the study described in chapter 5, we assessed with a training intervention 
whether the training response of the pathway that sets aerobic capacity would be 
modified by the ACE I/D gene polymorphism. 12 weeks of guided downhill skiing 
increased VO2max, capillary density and capillary-to-fiber ratio,  but not the 
concentration of metabolic proteins. Variability in the response of VO2max and heart 
rate at rest was related to the ACE I/D genotype of the subjects. We concluded that 
the different adjustments in heart rate and possibly muscle perfusion, contribute to 
the larger improvement in VO2max in subjects with the ACE-DD genotype. In this 
study we found that subjects carrying a D allele demonstrated larger improvements 
in VO2max and capillary length after the training stimulus of recreational skiing.  
 
The effect of ACE on AngII 
As described in the introduction, serum AngII is produced by conversion of 
AngI via endothelium-related ACE. At rest subjects with the ACE-ID or ACE-DD 
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genotype demonstrate approximately 30% and 60% higher levels of ACE activity, 
respectively, compared to subjects of the ACE-II genotype (Rigat et al. 1990). 
Subjects with the ACE-DD genotype are as well presumed to have higher AngII 
generation and resting AngII levels (Danser et al. 2007). This assumption is 
confirmed with the data from our study where subjects with the ACE-ID had 6.0% 
higher AngII levels at rest compared with the ACE-II genotype, whereby the ACE-DD 
genotype had 2.8 times higher AngII levels (table 3, page 78). During exercise the 
renin-agiotensin system is stimulated and several studies show increases in serum 
AngII concentration after severe exercise, without taking the ACE genotype in 
consideration (Aldigier et al. 1993, Miura 1994, Staessen 1987, Braith 1992, Kato 
(1996), Danielsen 1988, Fagard 1985). We found that not all subjects showed an 
increase in AngII after exercise (chapter 2). Subjects with the ACE-II genotype had 
significant higher AngII values at all the time points after the maximal test then 
people without the I allele, who demonstrate decreased AngII values after the 
maximal test (page 46). On the identified effect of ACE genotype on the AngII levels 
after the maximal test, we think the ACE genotype exerts a major influence on the 
standard error. Subjects with the ACE-II/ID genotype had a higher increase in AngII 
after exercise than subjects with the ACE-DD genotype, who even showed a slight 
decrease in AngII levels post exercise. Apparently the natural ACE inhibition that 
subjects with the ACE-II/ID genotype do demonstrate at rest is overridden during 
exercise when the renin-angiotensin system is stimulated, resulting in an increase in 
renin activity and higher ACE levels. The fact that AngII is mainly increased after 
exercise in subjects having the ACE-II genotype could also explain why not all 
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studies find an increase in AngII after exercise (Shim et al. 2008, Blanchet et al. 
2005). 
 
When inhibiting ACE levels with an ACE inhibitor, we found that these 
subjects showed an increase in AngII after exercise, confirming that during exercise 
ACE activity is less inhibited than at rest without considering the role of shear stress 
in regulating ACE . Subjects who did not consume the medication also had an higher 
average serum concentration of AngII, but this did not reach the level of statistical 
significance (chapter 3). This lack of significance is probably related by the fact that 
80% of the control subjects who did not take the ACE inhibitor appeared to have the 
ACE-DD genotype, and as stated before, subjects with this genotype have a less 
increase in AngII after exercise.  
 
The effect of ACE inhibition 
ACE inhibition is suggested to have a pro-angiogenic effect, with increasing 
capillary density and promotion of ischemia-induced angiogenesis (Gohlke et al. 
1997; Fabre et al. 1999). During endurance exercise the mRNA expression of pro-
angiogenic factors such as VEGF is increased in skeletal muscle (Gavin et al. 2000). 
In our study pro-angiogenic factors associated with the capillaries in the interstitium, 
i.e. VEGF and Tenascin-C were increased after exercise in the group who ingested 
the ACE inhibitor. This increase was much higher than in the group who did not take 
the ACE inhibitor. This highlights a possibl pro-angiogenic effect of ACE inhibitor in 
combination with endurance exercise. 
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Exercise in hypoxia produces a pronounced drop in muscle oxygenation. The 
oxygen dependent transcripts levels of HIF-1α and COX4I2 are regulated in a 
hypoxia-modulated manner after cycling exercise (Desplanches et al. 2014). In our 
study COX4I2 and HIF-1α were decreased after exercise in the group who took an 
ACE inhibitor (chapter 3, figure 2). Our findings support the view that an 
angiotensin-regulated mechanism affects the hypoxia-specific gene response in 
peripheral muscle to endurance exercise and support the notion that the muscle’s 
transcript regulation by ACE inhibition is related to muscle oxygenation during 
exercise.  This indicates that there is a shift in the activation of the gene program 
from muscle fibres to the surrounding interstitium after ACE inhibition.  
The effect of training upon ACE 
Endurance training increases the aerobic capacity. Subjects with the ACE-
II/ID genotype (natural inhibition of ACE) are used to have larger increases in 
aerobic capacity than subjects with the ACE-DD genotype after bicycle exercise 
training (Vaughan et al. 2013, Defoor et al. 2006). Increases in VO2-max after 
endurance training have been shown to be reflected by a locally exaggerated 
increase in mitochondria and capillary volume density (Hoppeler et al.  1985). In line 
with those results we identify a correlation between fold changes in VO2-max and the 
changes in capillary-to-fibre-ratio with ski training (Fig. 3, page 163). The identified 
trends for a decrease in heart rate, both at rest and during exercise, further indicate 
that central adaptations occur with the repeated downhill skiing (table 3, page 157). 
These observations suggest that the effects of improved capillarity in peripheral 
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muscle conspire with central changes to the gain in VO2max with ski training for the 
elderly subjects of our study.  
An intriguing aspect of our study was that variability in the cardiovascular 
response, based on measures of VO2-max and heart rate at rest, was related to the 
ACE I/D genotype (table 5, page 159). ACE I/D polymorphism affects the change in 
VO2max and muscle capillarity of young subjects to endurance training on stationary 
cycle ergometers (Vaughan et al. 2013). In that study subjects carrying the ACE I-
allele were found to demonstrate larger increases in aerobic capacity than non-
carriers of the I-allele, which only carry the D-allele (i.e. ACE-DD genotypes). On the 
other hand, in our study, subjects with the D-allele demonstrated larger 
improvements in VO2max and capillarity in m. vastus lateralis after a moderate 
endurance exercise stimulus. The present findings indicate a different influence of 
the ACE I/D polymorphism on the impact of concentric (i.e. cycle ergometer) versus 
eccentric (i.e. skiing) type of endurance exercise on aerobic capacity. Based on our 
data we hypothesize that different adjustments in cardiac performance, and possibly 
capillary perfusion of skeletal muscle, although the latter did not resolve at the level 
of statistical significance (p=0.17), contribute to the larger improvement in VO2-max 
in homozygous carriers of the ACE D-allele. 
Factors affecting ACE levels 
We have shown that the different levels of ACE can influence the effects of training. 
In our studies we saw that the ACE genotype is an important factor that plays a role. 
As differences in ACE levels between subjects can be accounted for about 20% for 
the I/D polymorphism (Danser et al. 2007), several additional factors must play a 
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role. As we have tried to control external factors that may influence the levels of 
circulating ACE, we may cannot generalize our conclusions to the whole population. 
Important factors that influence the ACE levels are gender, race, age, medical 
condition and BMI (provide a reference). We have studied healthy Caucasian males 
between 20 and 45 years of age, non-diabetic, non-hypertensive with a BMI 
between 20 and 30 kg/m2. As ACE and AngII levels have a circadian rhythm we 
tested within each subjects at the same time of the day when coming multiple times 
for a test. As we tested multiple subjects on one day we tested not all participants at 
the same time of the day. The circadian rhythm is also very hard to control for as 
subjects have different circadian rhythm of ACE and AngII. 
 
Limitations and further studies 
A limitation of this research is that it was not built on a cross-over design. This was 
explained by ethical and temporal constraints imposed for such an investigation 
under the granted doctoral fellowship. For the same reason a minimal number of 
subjects, was recruited in our investigation. This number was based on a prospective 
power analysis of pilot data with hypertensive subjects to meet the criteria for 
achieving a statistically significant difference for Tenascin-C transcript level changes 
pre vs. post endurance training (Zoll et al. 2006, unpublished).  
In order to identify a possible interaction effect between the ACE I/D gene 
polymorphism and Lisinopril an increase of the number of subjects would have been 
required to an extent that was out of the scope of the current investigation. As we 
have shown, the ACE I/D gene polymorphism influences the muscle response to 
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exercise, suggesting a critical role of ACE-modulated vascular tone, which is 
important for the regulation of exercise response. A study investigating in detail 
what the effect is of the ACE genotype in relation to exercise would be required. 
Such a study should contain sufficient subjects with the ACE-II, ACE-ID and ACE-DD 
genotype to be able to compare the different genotypes. In my latest paper, that 
was published during the revision of this thesis, we found that besides a regulation 
of the ACE protein, Lisinopril exerts effect on oxygen-modulated gene transcripts 
(COX4I1, COX4I2 and HIF-1a) and the ACE transcript itself in skeletal muscle. 
(Mathes et al. 2015). In this study we concluded that the response of ACE and 
COX4I2 transcripts post-exercise depends on the ACEI/D genotype. Despite the 
pronounced effects that we found in this study, caution applies when extending 
conclusions from our data to the general population because possibly many 
confounding variables interfere, which in our investigation were controlled by having 
subjects undergo a dominant one-legged exercise stimulus under standardized 
conditions. At the moment M. Flück is carrying out active research upon this topic. 
Population 
The population we measured in our study consisted of Caucasian men in the age 
group between 20 and 55 years of age. Most of the people who take ACE inhibitors 
are generally elderly. Within a subject, AngII increases above 55 years of age 
(Tsunoda et al. 1986). In the study of Chiang et al. (2006) it was shownin a large 
cohort study that elderly people with the ACE D-allele have a higher risk on 
developing hypertension. So when becoming older, the effect of ACE inhibition will 
be higher. The effect of ACE inhibition in our study, if we had  tested older subjects, 
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would probably have been more pronounced.  In this regard we think that the effect 
of the ACE genotype upon training and exercise is even stronger in the elderly. 
 
Effect on Health Care practice 
  We have shown that there are differences in AngII production after exercise 
between subjects having different ACE levels. AngII-targeted therapies are the 
current default treatment for hypertensive patients. Our findings that physiological 
improvements after exercise are dependent on ACE levels, both due to different ACE 
genotypes and to taking ACE inhibitors could have clinical repercussions. Differences 
in exercise-induced improvements have rarely been valued in pharmacological 
studies of hypertension and exercise rehabilitation (Böhm et al. 2008).  Awareness 
of the existence of such an influence of ACE levels could develop a major impact on 
current Health Care practice, particularly in exercise rehabilitation when one wants 
to exploit the sympatholytic and angiogenic benefits of physical therapy (Saltin et 
al.). It may explain the individual variation in the response to exercise rehabilitation 
in aerobic power and oxygen uptake (VanHees et al. 2005, Defoor et al. 2006). As of 
now the dose of the prescribed ACE inhibitors is only based on the severity of the 
hypertension, but this could be significantly improved by taking the ACE genotype of 
the patient into account. As we have shown, establishing the ACE genotype of a 
person can be easily obtained with a protocol using an ear bud twirling against the 
inner cheek. People with lower AngII levels at rest (e.g. ACEII genotype) could be 
prescribed a lower dose of ACE inhibitors. Besides establishing the ACE genotype it is 
crucial to know the physical activity level of the person. It is known that excercise 
has a positive influence upon the blood pressure. We have shown that the ACE 
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inhibition has influence on the physiological improvements in subjects who are 
already physical active. We assume that the found effects would be even stronger in 
inactive subjects. When prescribing ACE inhibitors it would be recommendend to 
take besides of the severity of the high blood pressure also the ACE genotype of the 
person and its activity level into account into account. The same profits, with even 
higher physiological improvements, could be obtained with a lower doses in many 
patients. As ACE inhibitors are widely prescribed, it could save costs for health care 
as well. 
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